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ABSTRACT  
Background: In sub-Saharan Africa the prognosis of children with type 1 diabetes is poor. 
Many are not diagnosed and those that are diagnosed have a reduced life expectancy (less 
than one year). This study set out to identify the factors that predict glucose control in 
children and adolescents with type 1 diabetes in the North West Region of Cameroon.  
 
Methods: A hospital based cross-sectional study involving 76 children/adolescents (41 girls 
and 35 boys, mean age of 15.1 ± 3.1 years) suffering from type 1 diabetes included in the 
“Changing Diabetes in Children” (CDiC) program and attending the clinics for children 
living with type 1 diabetes in the North West Region. Data on glycosylated haemoglobin 
(HbA1c) as well as clinical and biochemical parameters at diagnosis and during the study 
period were obtained from the hospital records of participants. A structured questionnaire 
was used to obtain information on socio-demographic characteristics and diabetes related 
practices from participants. Odds ratios (OR) were calculated using logistic regression to 
assess the association between determinants and good glucose control. 
 
Results: The study population had a mean HbA1c of 10.3 ± 2.9%. There was a significant 
decrease in the mean HbA1c from diagnosis (11.1%) to the study period (10.3%) (p = 
0.011). Multivariate analysis indicated that having a mother as the primary caregiver (OR 
0.02, 95% CI 0.002 – 0.189) and minimal/moderate caregiver involvement in insulin 
injection (OR 26.8, 95% CI 4.4 – 56.1) were independent predictors of glucose control. 
 
Conclusion: This study has demonstrated that having a mother as a primary caregiver is an 
important predictor of good glycaemic control among children with type 1 diabetes. It is 
currently unclear whether the direct involvement of the mother is important or whether 
“mother as a primary caregiver” is a strong indicator for a setting in which diabetes 
treatment is possible. 
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1. INTRODUCTION. 
1.1. Definition and classification of diabetes. 
Diabetes mellitus is a group of complex multifactorial metabolic disorders which is 
characterized mainly by hyperglycaemia resulting from defects in the action of insulin 
and/or the secretion of insulin1. The development of diabetes usually involves many 
pathogenic processes which may range from organ-specific autoimmune destruction of 
pancreatic beta (β) cells which are responsible for insulin secretion, characterized 
histologically by inflammation of islet cells2 and consequently abnormalities resulting in 
resistance to insulin1. The elevated plasma glucose is associated with chronic complications 
such as cardiovascular diseases, kidney disease, peripheral neuropathy with risk of foot 
ulcers and blindness1. Moreover, diabetes mellitus is currently a growing public health 
burden to the individual, the family and the society and its rates worldwide have reached 
alarming proportions3. 
 
Currently, diabetes is classified into four subtypes based on the etiology of the disease 
(Table 1). These include type 2 diabetes mellitus (T2D), type 1 diabetes mellitus (T1D), 
gestational diabetes as well as drug or chemically induced diabetes. This classification 
suggest that hyperglycaemia can be subcategorized into those that require insulin for 
survival, those requiring insulin for control (i.e. for metabolic control and not for survival) 
and those not requiring insulin (i.e. non-pharmacological treatment methods or treatment 
with drugs other than insulin)1,4. 
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Table 1.1: Etiologic classification of diabetes mellitus based on the position statement of 
the American Diabetes Association (ADA).1 
I Type 1 diabetes (destruction of β cell, usually associated with absolute 
insulin deficiency) 
• Immune mediated  diabetes (Type 1A) 
• Idiopathic diabetes (Type 1B) 
II Type 2 diabetes (resistance to  insulin with relative insulin deficiency and/or 
a defect of insulin secretion associated with insulin resistance) 
III Other specific types:  
A. Genetic defects of beta (β) cell function (e.g. MODY) 
B. Genetic defects in the action of insulin 
C. Exocrine pancreas diseases (e.g. pancreatitis) 
D. Endocrinopathies (e.g. Cushing’s syndrome, hyperthyroidism) 
E. Drug or chemical-induced (e.g. glucocorticoids, thyroid hormone) 
F. Infections (e.g. congenital rubella) 
G. Rare forms of immune-mediated diabetes (antibodies against insulin 
receptors) 
H. Other genetic syndromes associated with diabetes (e.g. Turner 
syndrome) 
IV Gestational diabetes  
MODY: Maturity onset diabetes of the young 
Source: American Diabetes Association1. 
 
1.1.1. Type 2 diabetes.  
Type 2 diabetes accounts for about 15% to 45% of all the newly diagnosed cases of diabetes 
in children and adolescents5, and 90% – 95% of all the cases of diabetes and it is as a result 
of a change in the balance between insulin secretion and sensitivity of insulin1. However, a 
study by Neu et al.6 reported that in German children type 2 diabetes is rare and that it was 
also the case in other European countries. Type 2 diabetes is most often characterized by 
insulin resistance with the individuals involved usually having a relative but not complete 
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insulin deficiency1. Also, the disease is very heterogeneous with respect to its genetic, 
metabolic as well as clinical characteristics.  
Type 2 diabetes incidence in children and adolescents has increased dramatically in some 
ethnic groups and countries since the 1990s. This has been attributed to increase in 
urbanization rates, economic development and this rise is mirroring increasing rates in 
overweight and obesity although the genetic predisposition of some ethnic populations 
might also be responsible for the rise7. For instance, a study by Pinhas-Hamiel and Zeitler5 
found that about 80% of all new cases of pediatric diabetes in Japan are type 2. On the 
contrary in the UK, among children less than 17 years type 2 diabetes was less common with 
a minimum incidence of 0.53 per 100,000 children/year observed8. Finally, type 2 diabetes 
is frequently linked with obesity1,7 (predominantly fat distribution around the abdomen) and 
lack of physical activity and it is also characterized by older age of onset. 
 
1.1.2. Type 1 diabetes (T1D). 
Type 1 diabetes is the most common form of diabetes in childhood and it is characterized by 
deficiency in insulin resulting from the autoimmune destruction of pancreatic β-cells9, 10,11, 
in genetically susceptible individuals. It accounts for about 5% – 10% of all the cases of 
diabetes with a majority of the patients (approximately 40%) diagnosed before the age of 
2012,13. Impairment in the secretion of insulin and deficiency in the action of insulin is 
usually the main cause of the elevated blood sugar in individuals with type 1 diabetes. 
Polyuria, weight loss, polydipsia and blurred vision are most often the consequences of the 
elevated plasma glucose levels. Also, susceptibility to certain infections and growth 
retardation may also be associated with the very high blood sugar14.  
 
Etiologically, type 1 diabetes might be subdivided into two groups which include; 
autoimmune (immune-mediated) and idiopathic. The autoimmune group (type 1A) is 
polygenic, accounts for about 80% – 90% of all T1D cases and it is the most frequent type 
of the disease whereas, type 1B also known as idiopathic, presents with all the clinical 
features of the autoimmune group except for the autoimmune aspect15.  
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Type 1 diabetes is also the form of diabetes that requires life insulin therapy, but the 
metabolic characteristics vary considerably, both before and at diagnosis16. Moreover, 
autoantibodies associated to diabetes are not always sufficient to define a categorical disease 
phenotype since patients who evolve to insulin requirement are usually characterized by 
both autoantibodies and younger age at diagnosis, little endogenous secretion of insulin, 
lower body mass index and high levels of glycosylated haemoglobin (HbA1c) at the time of 
diagnosis (Figure 1.1). Therefore, juvenile-onset of T1D is the most genetically determined 
and most severe form of the disease.  
Further, T1D has traditionally been considered a disease of childhood and early adulthood. 
However, recent data suggest that only about 50% – 60% of those with type 1 diabetes are 
less than 18 years at presentation and that the disease also occurs throughout adulthood but 
the incidence level is low17. 
 
Figure 1.1: The range of diabetes covers variable risk according to the type of diabetes for 
immune changes, the age at presentation, obesity (assessed by body mass index), HLA 
genetic susceptibility and treatment with insulin (Figure and legend from Leslie et al. 
2008)16. 
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1.1.3. Pathophysiology of type 1 diabetes. 
The deficiency of insulin in T1D may be seen as a result of the beta (β) cell damage within 
the pancreas resulting in autoimmunity in individuals who are genetically susceptible2. The 
β-cells are glucose automatic regulators, which control the release of insulin to maintain 
physiological glucose levels10. The process of producing antibodies against islet cells as a 
result of this process is a marker of the onset of an autoimmune disease activated by 
autoreactive T cells. These T cells which are capable of destroying β cells result in a gradual 
loss in its insulin secretory function9.  
Given that clinical T1D (i.e. presence of symptoms) does not present until about 80% to 
90% of the β cells have been destroyed, there is a noticeable gap between the onset of 
autoimmunity and the onset of diabetes (Figure 1.2). A recent study by Atkinson9 suggest 
that 40% to 50% of β cells are viable at the onset of hyperglycemia and this might be the 
reason why the secretion of insulin may remain stable for long periods in persons with T1D 
despite the production of autoantibodies. A loss of first-phase insulin response (as measured 
by intravenous glucose tolerance) is generally followed by a period of intolerance to glucose 
and also a period of clinically ‘silent’ diabetes18 which usually occurs when the regenerative 
capabilities of the beta cells is overwhelmed by autoimmunity.  
Several studies have identified a series of autoantigens as markers for autoimmunity in 
patients with T1D including autoantibodies to insulin (IAA), islet cytoplasmic 
autoantibodies (ICA), autoantibodies to the 65-kD form of glutamic acid decarboxylase 
(GADA)19, tyrosine phosphatase-related islet antigen 2 (IA-2)20 as well as autoantibodies 
against the zinc transporter ZnT8 (Slc30A8) 21. Even though a study by von Herrath et al.22 
suggested that there may be three or more antigens at the beginning of the process of 
autoimmunity against pancreatic beta cells, the authors concluded there is no consensus on 
the exact nature and immunological process associated with the primary autoantigen that 
occurs in T1D, as many antigens are involved in activating the process at the end. 
A study in Cameroon by Hawa et al.23 to evaluate the presence of autoantibodies in 47 
patients with type 1 diabetes reported that 34% and 6.4% had GAD and IA2 autoantibodies 
respectively. Nevertheless, this study was carried out in adult type 1 diabetic patients and the 
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findings may not reflect the situation among children and adolescents with type 1 diabetes. 
In another study in Tanzania by Lutale et al.24 to assess the occurrence of autoimmune 
mediated type 1 diabetes, the authors found that 29.8% of the patients had GADA and 
21.3% had IA-2A and the frequencies of these pancreatic autoantibodies was lower than that 
observed in Caucasian populations. Also, the overall prevalence of islet cell antibodies 
(ICA) was reported to be 42.6% among patients with T1D compared to 7.3% among type 2 
diabetic patients. The authors attributed the significant presence of autoantibodies in most 
type 1 diabetic patients with a positive family history of diabetes. In addition, a study from 
Tunisia among newly diagnosed children with type 1 diabetes found a higher prevalence of 
autoimmune markers with 90.7% of the children having at least one autoantibody25. In this 
study 57% of the patients were positive for islet cell antibodies (ICA), 65.1% had GADA, 
43% had IA-2A and 50% had IAA. This is an indication that most of the cases of type 1 
diabetes in African children may be considered as immune mediated.  
 
Figure 1.2: Model of type 1 diabetes natural history and pathogenesis. This model expands 
on the traditional model by including information which has been gained through an 
improved understanding of the roles for immunology, genetics and environment in the 
natural history of T1D (Figure and legend from Atkinson, 2012) 9 .  
 
Research has been able to identify the contribution of genetics to the risk of the disease and 
among all the genes which have been linked with type 1 diabetes, the human leucocyte 
antigen (HLA) was found to have the strongest association26. T1D does not conform to any 
of the simple inheritance patterns in spite of the obvious effect of genetic factors, as such it 
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is still considered a complex and multigenetic disorder26. In addition, studies have confirmed 
the effect of genetics and the environment in type 1 diabetes. For instance, the risk of type 1 
diabetes was 1 in 20 for an individual in the United States (US) having a first degree relative 
with T1D, whereas the general population had a 1 in 300 risk27. Again, studies on 
monozygotic twins have shown the risk to be between 30% – 50%, meanwhile, dizygotic 
twins had a concordance of 6% – 10%28. 
 
1.1.4. Environmental risk factors for type 1 diabetes.   
Evidence has implicated the role of exogenous factors in the development of T1D as triggers 
and enhancers of β-cell destruction29,30. Studies among monozygotic twins have found a 
pairwise concordance of < 40%31,32, implying that there is either an acquired 
postconceptional genetic discordance or the role of non-genetically determined factors. 
Also, studies have reported that of all the individuals with the HLA diabetes susceptibility 
genes, less than 10% develop the clinical disease33,34, and this may be explained by the 
powerful influence of one or more environmental triggers. In addition, a steep global rise in 
the incidence of T1D in childhood in the last five decades, most especially in Europe35 with 
a more than ten-fold difference in disease incidence has been reported among children below 
15 years of age living in Europe36. This cannot exclusively be due to the increased genetic 
disease susceptibility in the population but most likely reflect changes in lifestyle and the 
environment. Moreover, data on migrant studies from population groups who have moved 
from low-incidence to high-incidence regions indicate an increase in T1D incidence, 
underscoring the influence of exogenous factors37.  
The exact mechanism responsible for the process leading to autoimmunity remains 
unknown38. However, putative triggers including infectious agents (e.g. enteroviruses, 
coxsackie, congenital rubella) or components of early diet (cow milk protein, cereal or 
gluten exposure)39,40, are thought to initiate the process of autoimmunity, leading to 
extensive β cell destruction and ultimately clinical manifestation of type 1 diabetes. Also, 
environmental factors playing a role in the pathogenesis of T1D may differ substantially 
from population to population given different exposures to a given risk factor or because of 
the genetic susceptibilities of populations to the risk factor41. These may include perinatal 
8 
 
factors42,43, increased weight gain during infancy44,45, exposure to sunlight  and vitamin D 
sufficiency46,47 and dietary factors48 .  
In addition, Cardwell et al.49 in a meta-analysis demonstrated that children from caesarean 
section delivery have an increased risk of childhood type 1 diabetes. Given the 
disproportional influences of maternal factors on the risk of T1D is suggestive of critical 
disease-inducing environmental events that operate very early in life (even in the uterus) and 
these maternal-related events are associated with an increased risk of the disease in children 
which is not the case in adults50.  
 
Maternal habits during pregnancy. 
Maternal habits during pregnancy such as tea drinking and smoking have been shown to be 
associated with an increased risk for type 1 diabetes in their children41,51. For instance, 
Majeed and Hassan51, in a study in Basrah realized that the drinking of tea, exposure to 
environmental risk factors (pre-eclampsia, and infectious diseases) during pregnancy and 
neonatal period (jaundice and infections) in early infancy were significantly associated with 
the development of type 1 diabetes.  Also, a study in Italy reported similar findings41. 
Another Swedish study also reported that maternal smoking (> 9 cigarettes a day) in early 
pregnancy was associated with a higher risk (OR 3.91) of the child developing type 1 
diabetes52. 
 
Maternal age at delivery. 
Maternal age at delivery has been found to be a high risk factor of T1D in their offspring 
with the risk being highest in firstborns53. However, evidence on the role of maternal and 
neonatal factors in the development of childhood T1D is inconclusive. While several studies 
have found a significant association between increased maternal age with an increased risk 
of type 1 diabetes 43,54, others have not found any association55,56. 
 
Breastfeeding. 
Breastfeeding has been proven to have a protective effect against T1D while cow milk 
increases the risk of developing type 1 diabetes34,57. A previous study found concomitant 
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diseases and early infant nutrition to be some of the environmental risk factors associated 
with the development of childhood type 1 diabetes48. For example, a study by Visalli et al.41 
in Italy on genetically susceptible T1D individuals found that breast feeding for less than 
three months and the presence of eczema were risk factors for T1D in this Southern 
European population. Also, early weaning, and suspension of breast feeding for cow milk 
formula before 3 months of life were all higher for type 1 diabetics than for non-diabetics in 
the same study.  
 
Birth weight. 
A previous study suggests that birth weight and weight gained during infancy or the first 
year of life are associated with an increased risk of developing T1D later in life58. Also, a 
study in South Iran has shown that increased birth weight ( ≥ 4kg) is a potential  risk factor 
for type 1 diabetes (OR 2.04)59, while in a meta-analysis by Harder et al.60, low birth weight 
(< 2,5kg) was associated with a decreased risk of type 1 diabetes. The authors reported that 
every 1 kg increase in birth weight was associated with a 7% increase risk of developing 
type 1 diabetes. 
 
1.2. Global situation of type 1 diabetes mellitus. 
1.2.1. Incidence and prevalence of type 1 diabetes mellitus from a global perspective. 
Despite tremendous progress by developed nations to improve access to diabetes care and 
adequate management of the disease, type 1 diabetes remains a growing public health 
concern given the upturn in incidence, a trend that is currently observed worldwide14,61. This 
present situation has been described as the most challenging health problem of the 21st 
century62, with an estimated 542,000 children (under the age of 15) worldwide living with 
type 1 diabetes and 86,000 developing type 1 diabetes annually14.  
Like the rest of the world, sub-Saharan Africa is not exempted from diabetes and the 
increasing number of families affected remains a challenge63,64. Also, over the past decades, 
diabetes has emerged as a major health challenge in the region65,66, where an estimated 14.2 
million adults aged 20 – 79 years are now estimated to have type 2 diabetes and 46,400 
children (below the age of 14) are suffering from type 1 diabetes14. Notwithstanding, T1D 
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among children in sub-Saharan Africa has a high rate of mortality and less than half of these 
children are diagnosed64. What is more daunting is the fact that compared to countries in the 
developed world, children diagnosed in developing countries have a reduced life expectancy 
(less than one year)64,67. 
 
Large international collaborative studies such as the Diabetes Mondiale study (DIAMOND) 
68
, the Europe and Diabetes study (EURODIAB) 69 and the SEARCH for diabetes in youth 
study70, during the last decades have offered significant contributions to global trends in the 
incidence and epidemiology of the disease. These studies have reported an upward trend in 
the incidence of T1D among children under the age of 15 years in many countries with an 
overall annual increase estimated at 3%68,69.  Nonetheless, a large geographical variability in 
the incidence rates of childhood type 1 diabetes have been reported71.  In Western countries, 
the prevalence has been found to be higher compared to the African region partly due to 
higher surveillance and diagnostic rates in the developed world compared to Africa.  
In 2015, according to the International Diabetes Federation (IDF) Diabetes Atlas14, of the 
estimated 542,000 children living with type 1 diabetes, 46,400 were estimated to be living in 
Africa alone with 7,600 children newly diagnosed annually. In addition, 26% of the newly 
diagnosed children globally came from Europe and 22% from the Caribbean and North 
America14. 
 
Table 1.2: Global estimates of type 1 diabetes in children (< 15 years). 
Parameter 2015 
Child population  1.9 billion 
Number of children with type 1 diabetes 542,000 
Number of new type 1 diabetes cases per year 86,000 
Annual increase in incidence 3%* 
Source: Diabetes Atlas 7th edition International Diabetes Federation, 2015. 
*Estimates from the Diabetes Mondiale study (DIAMOND) 68, the Europe and Diabetes study (EURODIAB) 69 
 
According to data from the DIAMOND study there was a 350-fold variability in incidence 
levels across the studied populations between 1990 and 1999. In Europe, the annual 
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incidence in most countries from 1989 to 2003 was found to be increasing with an overall 
annual increase of 3.9%69. Finland had the highest incidence (40 cases per 100,000 children 
at risk) of type 1 diabetes worldwide, whereas the lowest incidence (0.1 cases per 100,000 
children per year) was reported in the Zunyi region in China68,72. These studies also 
described large intercontinental variation in incidence rates.  
 
In the USA, the estimated prevalence of diabetes in 2009 (both T1D and T2D) in people 
younger than 20 years was 0.22%73, implying that 1 in every 433 persons less than 20 years 
had diabetes. Also, an annual prevalence for type 1 diabetes was estimated at 1.93 per 1,000 
in children less than 20 years in 200973. Among South American populations, the incidence 
varied between very low to high (2-10 per 100,000/year), whereas in Central America the 
variation ranged from 1.5 to 17/100,000/year.  
 
Europe is a region with the most informative and reliable data on incidence where a north to 
south gradient has been described, varying from the highest in Finland (43.9/100,000/year) 
and some of the other Scandinavian countries to the lowest being reported in Macedonia 
(3.2/100,000/year)36,74,75.  
A study in the Karnataka region of India, reported an annual incidence of 0.32/100,000 per 
year based on a diabetes registry from 1995 to 200876. 
  
There are only a few African studies in the literature that have reported the incidence and 
prevalence of T1D. Most of the studies are hospital-based as opposed to population based 
studies conducted about two to three decades ago; therefore the true population prevalence 
remains unknown. As a result of scarcity of data in the African continent, the region’s 
contribution to global estimate of type 1 diabetes incidence is low. However, in children less 
than 14 years in the African region, an incidence estimate of 6.4/100,000 per year of new 
cases of T1D has been reported77. The high childhood mortality rates in the African 
continent may contribute to the low ascertainment of cases in countries where incidence data 
does exist.  For instance, studies from North Africa have shown that the incidence varies, 
ranging from 4.4/100,000 in Algeria78 to 20/100,000 in Morocco79. Moreover, only Sudan 
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and Tanzania in sub-Saharan Africa have data on T1D incidence. Incidence estimates from 
Sudan, indicated that the incidence increased from 9.5/100,000 to 10.3/100,000 in 1991 and 
1995 respectively80,81. In addition, an incidence of 1.5/100,000 per year was estimated for 
Tanzania82. However, the data used in this study was from 1991 and follow up studies have 
not yet been carried out. 
 
Of particular concern is the rising incidence of type 1 diabetes in the youngest age group, 
affecting mostly the poor and posing a threat to the fragile health systems in most low 
income countries. Most children who develop diabetes early are more at risk of developing 
long-term complications. In addition, many countries in the African region are yet to 
prioritize diabetes in their health systems despite evidence of the health and economic 
effects of the disease83. Although, a lot of research has been done worldwide to determine 
and document the increasing incidence of T2D, comparatively very little attention has been 
focused on type 1 diabetes in the developing countries. Therefore, more efforts are needed in 
the African region, especially in sub-Saharan African countries to collect data and generate 
enough evidence in order for the governments of this region to see the impact of type 1 
diabetes in this vulnerable group. 
 
1.2.2. Within country variation. 
Within-country variation in incidence rates has been reported in some of the Scandinavian 
and European countries such as Sweden84, Finland85, Italy86 and Sardinia87 with a 5-fold 
higher rate in the island of Sardinia compared to mainland Italy75. Also, a higher incidence 
in the rural than in the urban areas has been shown in studies from Finland88, Sweden89 and 
Northern Ireland90. On the contrary, reports from Lithuania91 and Italy86 have shown the 
opposite.  
Geographical variability in incidence rates among children with T1D may be associated with 
ethnic differences and socioeconomic variables between rural and urban areas as well as 
population density.  
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1.2.3.  Ethnicity. 
According to the SEARCH for diabetes in youth study, T1D incidence rates vary 
remarkably between races and ethnic groups. Also, the risk is much higher among 
Caucasians, less in African – American blacks and extremely low in Asians and Pacific 
Islanders and this is strongly related with incidence variation across countries. 
In addition, available data from the SEARCH study reported T1D incidence to be highest 
among non-Hispanic white children with a slightly higher incidence rate for males than 
females (24.5/100,000 for males and 22.7/100,000 for females) followed by African-
American youth (15.7/100,000) for those 0 - 9 years old and 10 - 19 years old during 2002 – 
2005) and for Hispanic youth (16.2/100,000 and 15.0/100,000) for boys and girls aged 0 - 14 
years. 
 
A migrant study among German residents, comparing the incidence of T1D in German 
children as opposed to Italian children originating from a very high-risk region (Sardinia) 
and from areas of medium-risk (continental Italy) indicated that children from Italy with 
T1D had incidence rates that were nearer to those of their country of origin than to those of 
German children92. This finding points to the fact that genetic factors play a powerful role in 
the development of T1D. Incidence rates were lowest among Asian and Pacific Islanders 
youth (6.4/100,000 and 7.4/100,000 in those 0 – 9 years and 10 – 19 years of age 
respectively)75. 
 
1.2.4. Seasonality at diabetes onset. 
Many studies in the developed world have found evidence on a seasonal pattern in the onset 
or diagnosis of type 1 diabetes in children with a peak during the colder months as opposed 
to the warm months. However, the results so far are conflicting.  Although some studies 
have found evidence for seasonality93,94, a study by Padaiga et al.95 did not while another 
study only found seasonality in subpopulation groups96. Also, seasonal variation at diagnosis 
appeared to be different in the younger and older children implying a possible role of 
environmental factors in the development of the disease. 
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1.2.5. Seasonality at birth.  
With regards to seasonality at birth, several epidemiological studies have also reported a 
seasonal pattern at birth with a higher incidence for children born in summer and spring 
compared to those born in autumn and winter94,97. Notwithstanding, little evidence has been 
found to support the theory that environmental factors operating during foetal or neonatal 
life as a result of a particular season have any influence on type 1 diabetes development later 
in life98. 
 
1.2.6. Age  
Type 1 diabetes incidence shows an age-dependent pattern with the incidence increasing 
from birth to 12 years, with a peak between 10-14 years of age, before dropping to a much 
lower rate99. Nevertheless, studies from African populations among type 1 diabetics have 
shown a peak incidence to occur a decade later (i.e. 20 – 29 years of age) compared to what 
is seen in Caucasians100. In addition, the reasons for this delayed age at diabetes onset 
among Africans are still unknown. A study in rural Ethiopia showed that the disease 
phenotype observed in this part of Africa was mostly among young adult males and it was 
different from the classical form of T1D observed in Western countries but conformed to the 
descriptions of malnutrition – related diabetes, a category of diabetes which is not 
recognized in the current classification of diabetes by WHO100. Also, the rising worldwide 
incidence of type 1 diabetes is especially marked in the youngest children (0 – 4 years)101. 
 
1.2.7. Gender  
Although data from different regions suggest that in populations of high – incidence there is 
a slight male excess and a minor female excess in low-incidence populations91, on average 
both genders carry similar risks. While male excess has been observed among populations of 
European origins, a slight female predominance has been reported in African populations.  
For instance, studies carried out in Egypt and South Africa among children with type 1 
diabetes, reported a slightly higher incidence among females compared to males102,103 with 
most of the cases coming from the rural areas. In contrast, a study which was carried out 
among children with type 1 diabetes in Nigeria reported a male predominance104. 
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1.3. Diagnosis, presentation, management and complications of diabetes mellitus. 
1.3.1. Diagnosis of type 1 diabetes.  
Diabetes in children usually present with characteristic symptoms such as unexplained 
weight-loss, polyuria, ketonuria, polydipsia, blurring of vision, glycosuria as well as 
drowsiness and coma in severe cases1,105 and clinical diagnosis of diabetes is often prompted 
by these symptoms. Current guidelines of the American Diabetes Association (ADA) 
recommend that diagnosis of diabetes in children and adolescents should be done using the 
World Health Organization (WHO) report of 1999106 and the guidelines of the International 
Society for Pediatric and Adolescent Diabetes (ISPAD)105. The diagnostic criteria for 
diabetes are based on the presence or absence of characteristic symptoms and additionally 
on any of the criteria below107: 
 
Table 1.3: Criteria for diagnosing diabetes according to the American Diabetes Association 
(ADA)107. 
1 HbA1c † ≥ 6.5 %. This test should be done using an NGSP certified method and 
standardized to the DCCT† assay.* 
 OR 
2 FPG† ≥126mg/dL (7.0 mmol/L). Fasting is defined as no intake of food for at least 
8 hours.* 
 OR 
3 Two-hour plasma glucose ≥ 200 mg/dL or 11.1 mmol/L during an OGTT†. This 
test should be performed according to World Health Organization criteria, using a 
75 g of glucose dissolved in water.* 
 OR 
4 Patients with classic symptoms of high blood sugar or a random plasma glucose ≥ 
200 mg/dL or 11.1 mmol/L. 
*In the absence of unequivocal hyperglycemia, the test can be repeated to confirm the results. †HbA1c, 
glycosylated haemoglobin;  NGSP, National Glycoheamoglobin Standardization Program; FPG, Fasting 
plasma glucose; OGTT, Oral glucose tolerance test;  DCCT, Diabetes Control and Complications Trial. 
The current guidelines published by the World Health Organization (WHO) done in 
consultation with the International Diabetes Federation (IDF) in 2006  recommends using 
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fasting plasma glucose values of ≥ 126mg/dL (7 mmol/l) or a 2 hour plasma glucose value 
of ≥ 200 mg/dL (11.1 mmol/l) during an OGTT as diagnostic criteria. In addition, diagnosis 
of diabetes should be standardized to the Diabetes Control and Complications Trial (DCCT) 
assay. 
 
1.3.2. Clinical presentation of diabetes in children and adolescents.   
Pediatric type 1 diabetes is characterized by stages ranging from an asymptomatic 
preclinical phase, clinical presentation, partial remission or honey moon phase and finally a 
chronic established lifelong insulin-dependent phase108. Preclinical diabetes is the phase 
before clinical presentation during which markers of autoimmunity may be identified. 
Depending on the type of diabetes and age at onset, manifestation may differ from patient to 
patient given the fact that the time interval between abnormalities in glucose control until 
the development of symptoms is usually very brief. Children with type 1 diabetes usually 
present with classical symptoms such as polydipsia, polyuria, polyphagia and weight loss. In 
addition, most children with type 1 diabetes present with metabolic deterioration leading to 
diabetic ketoacidosis (an event which is life threatening), presenting with nausea, lethargy, 
vomiting and dehydration109.  
After clinical diagnosis and following initiation of insulin therapy is the honeymoon or 
partial remission period during which the insulin requirement in about 42% - 80% of 
children and adolescents decreases transiently while good glycaemic control is 
maintained110,111. This has been associated with the fact that the remaining beta cells that are 
exhausted but not yet destroyed restore endogenous insulin production with the alleviation 
of hyperglycemia111,112. The partial remission phase usually commences within days to 
weeks after the start of insulin therapy and may last for weeks to months108. A study has 
reported that the mean duration of the partial remission period is 11.7 +/- 8.9 months113 and 
in some cases the requirements for insulin may decrease to the point of being able to 
temporary withdraw insulin therapy and still be able to maintain normoglycaemia108,114. This 
partial remission phase is always short-lived and evolves to the lifelong insulin dependence 
chronic phase. Therefore, in certain cases, the diagnosis of diabetes should be considered in 
the absence of the classic symptoms. For instance, in children who present with an acute 
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febrile illness from whom elevated plasma glucose levels are obtained as part of their 
laboratory diagnosis. 
 
1.3.3. Management of type 1 diabetes in children and adolescents. 
The management of diabetes involves continuous medical care and patient self-management 
education in order to prevent acute complications107 such as diabetic ketoacidosis (DKA) 
and hypoglycemia which are the major causes of morbidity and death in younger 
patients61,115 and the risk of long-term complications116,117. Therefore, prevention of long-
term complications is the major focus of diabetes management in younger and adolescents 
patients with longer diabetes duration. However, pediatric diabetes management has 
remained a major challenge to the patient, the healthcare provider as well as family members 
of the patients118,119,120. 
Current recommendations emphasize on the use of intensive insulin therapy which can 
either be administered by the use of multiple insulin injections (3 – 4 injections a day of 
basal and prandial insulin) or a continuous subcutaneous insulin infusion (CSII)121. Blood 
glucose monitoring as well as dietary and lifestyle modification have also been found to play 
an important role in the management of the disease122. Despite, the recommendations for the 
proper management of type 1 diabetes in children and adolescents, the anticipated 
improvement in glycaemic control is still to be achieved in all settings. 
 
Glycaemic control. 
The Diabetes Control and Complication Trial (DCCT), in individuals with T1D, 
demonstrated that strict glycaemic control delayed the onset as well as slowed the 
progression of long-term complications such as kidney disease, nerve problems and visual 
problems by 35-76 %116,123. Glycaemic control is routinely monitored by the use of 
glycosylated haemoglobin (HbA1c). Its value indicates the glycaemic control over the past 2 
to 3 months; values below 7.5% are considered better according to the American Diabetes 
Association (ADA) standards for diabetes care107. Also, it is the most reliable method used 
to set the target values for glucose control and for evaluating treatment effectiveness117.  
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The current guidelines of the ADA recommend an HbA1c goal of < 7.5% across all 
pediatric age-groups107. However, individualization is still encouraged. For instance,  an 
HbA1c of 7.5% - 8.5% , < 8% and < 7.5% for children less than 6 years, 6 – 12 years and 13 
– 19 years respectively122. These recommendations considered the benefits of strict 
glycaemic control against the risk of hypoglycemia especially in the younger patients107,124, 
given the detrimental effects of hypoglycemia to the developing brain of younger patients. 
The adolescence group had a 0.5% higher HbA1c target than the recommendation for adults 
with T1D because this is a period of hormonal changes and achieving target HbA1c levels 
might be very challenging. Furthermore, although the current recommendations from the 
ADA107 state that good glycaemic control is HbA1c < 7.5%, these goals are very difficult to 
achieve even in clinical trial settings. Even so, for individuals with severe anaemias 
especially in sub-Saharan Africa, HbA1c might not be a very good marker for glucose 
control since it gives falsely low readings, thus potentially reducing its usefulness in this 
region of the world. 
There exists a wide variation in the level of glycaemic control in children with T1D between 
Africa and the developed economies.  Glycaemic control in children with type 1 diabetes is 
improving in the industrialized countries while that is not the case in the African 
region125,126. For instance, in the American-based SEARCH for diabetes in youth study, a 
mean HbA1c of 8.18% was reported73, while in the largest study from German and Austrian 
pediatric T1D (27,035 children with T1D in 207 pediatric centers) showed a median HbA1c 
value of 7.8%127. Comparatively, studies in Sudan128 and Tanzania126 have reported mean 
HbA1c of 9.3% and 10.65% respectively.  
 
Blood glucose monitoring. 
Self-monitoring of blood glucose is one of the key components in the management of type 1 
diabetes in children and adolescents since it plays a vital role in evaluating individual 
response to therapy107. Also, this helps in preventing acute and chronic complications122,129, 
thereby preventing many hospitalizations130. Based on these blood glucose results the 
physician can be able to alter the insulin regimen for the patient accordingly.  
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Current guidelines of the ADA recommend that patients with type 1 diabetes measure their 
blood glucose at least 6 to 8 times a day107,117.  However, recommendations for the number 
of checks per day vary for each individual, depending on different factors (e.g. insulin 
regimen, diet and the ability to responsibly manage T1D) as well as the clinical needs of the 
patient. For instance, it is recommended that type 1 diabetics should check their blood 
glucose at least 4 times a day131. In addition, patients in the intensive treatment group of the 
Diabetes Control and Complications Trial116 performed at least 4 blood sugar measurements 
every day. Therefore, for all people with diabetes, 3 or 4 blood sugar checks a day is a 
reasonable goal. Several studies have shown that there is a strong correlation between the 
glycaemic control and the frequency of blood glucose monitoring daily among children with 
type 1 diabetes119, 132.  
For example, a study by Ziegler et al.133 involving 26,723 type 1 diabetic children and 
adolescents aged 0 – 18 years found that increased frequency of self-monitoring of blood 
glucose daily was related to better metabolic control in adolescents above 12 years of age 
but not in younger children irrespective of the treatment regimen. Similarly, a Danish 
nationwide study among type 1 diabetes patients aged 0 – 14 years diagnosed from 1996 to 
2006 reported a reduction in HbA1c with increased frequency of self-monitoring of blood 
glucose125. Also, Murata et al.134 in a study among adult patients with type 1 diabetes in 
Japan found that individuals who measured their blood glucose at least 3.5 times a day had 
improved glycaemic control compared to patients who did less than 3.5 measurements daily. 
Notwithstanding, the relatively small sample size and cross-sectional nature of the study are 
limiting factors in the ability to establish a causal relationship between blood glucose 
monitoring and HbA1c.   On the contrary, self-monitoring of blood glucose was not found to 
be associated with better glycaemic control among Sudanese patients with diabetes135.  
Nevertheless, this study involved men and women with type 1 and type 2 diabetes and the 
results may not be reflective of the situation among children and adolescents with type 1 
diabetes. 
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Diet and physical activity. 
Diet as well as physical activity plays a vital role in the management plan of type 1 diabetic 
subjects. However, it is the most difficult aspect of treatment in children and adults. Current 
recommendations for diet in children and adolescents with type 1 diabetes are focused on 
achieving normal blood glucose levels without being accompanied by excess hypoglycaemic 
episodes124, meanwhile for physical activity, they are advised to perform moderate physical 
activity for at least 60 minutes/day107. Proper nutrition is essential for growth and energy 
with close adherence to dietary recommendations playing a significant role in improving 
glucose control in children and adolescents136.  
Studies have demonstrated the influence of physical activity on glycaemic control in 
children with type 1 diabetes. For instance, a study by Cuenca-García et al.137 among 
children 8 to 16 years from a Paediatric Diabetes Service in South West England showed 
that moderate-to-vigorous physical activity was associated with improved glycaemic 
control. Similarly, a meta-analysis by Miculis et al.138 has also shown that physical activity 
plays a vital role in the treatment of children and adolescents with type 1 diabetes.  
 
1.3.4. Complications of diabetes mellitus. 
The biochemical alterations in type 1 diabetes results in complications which can be divided 
into short-term or acute complications (hypoglycemia and diabetic ketoacidosis) and long-
term or chronic complications (i.e. microvascular and macrovascular). The components of 
microvascular complications include nephropathy, retinopathy and neuropathy (outcomes 
are visual impairment and blindness, renal failure, hypertension as well as muscle weakness 
and autonomic dysfunction respectively), while the components of macrovascular 
complications include, cardiovascular, cerebrovascular and peripheral vascular diseases139.  
A majority of the chronic complications are being attributed to the non-enzymatic 
glycosylation of protein residues in the nerves, blood vessels and renal glomeruli140,141.  
In developed countries, enormous efforts have been made to reduce chronic complications 
of diabetes; meanwhile the same cannot be said about developing countries especially sub-
Saharan Africa. Also, the management of complications in many developing countries is 
very difficult due to paucity of data on the true burden of the disease among diabetic 
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children; although high rates of microvascular and macrovascular complications of the 
disease have been reported among adults. Nevertheless, the occurrence of new cases of 
paediatric T1D in many sub-Saharan countries has been reported alongside the growing 
disease prevalence, demonstrating the importance of assessing for chronic complications142, 
143
.  
 
Diabetic ketoacidosis (DKA). 
Diabetic ketoacidosis is an acute life threatening metabolic deterioration which is 
characterized by ketonuria, high blood sugar and acidosis. It presents in 15% - 70% of 
children and adolescents newly diagnosed of type 1 diabetes 141 and it is a major cause of 
morbidity and mortality61,144. Children who present with diabetic ketoacidosis usually 
manifest as dehydration, vomiting, abdominal pain, acidotic breathing or rapid deep 
respiration (or Kussmaul’s breathing), altered mental status and coma109. There seem to be a 
wide variation in the range of children presenting with diabetic ketoacidosis at diagnosis 
depending on the study population. A study has reported DKA at diagnosis to be more 
common among children in developing countries partly because access to medical care is 
limited and practitioners are less familiar with the symptoms of DKA145.  
Previous studies have reported the frequency of DKA to vary from 80% to 88%80,146,147. For 
instance, in Tanzania, 75% of children presented with DKA at diagnosis125, while in Saudi 
Arabia, 79.8% of children with newly diagnosed type 1 diabetes presented with DKA148.  
Also, a study in Iran reported that 24% of children presented with DKA at diagnosis149. 
Nonetheless, DKA still remains a significant complication of type 1 diabetes which is 
associated with a variety of adverse events150. Therefore, focus on early diagnosis and 
intervention in children who have been newly diagnosed with the disease might help in 
reducing the frequency of DKA.  
 
Hypoglycemia. 
Hypoglycemia is the most frequent acute complication of type 1 diabetes and it is a limiting 
factor in attaining glycaemic targets in paediatric diabetic patients151,152. Although, it may 
become life-threatening, it rarely leads to death if left untreated since hypoglycaemia 
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activates a counter regulatory system of stress hormones in order to stop the glucose level 
from dropping thereby bringing about unpleasant symptoms, such as rapid heartbeat, 
increased sweating, shaking, hunger and difficulty in concentrating.  
Studies have shown that hypoglycemia appears to be more common among premature 
newborns153, 154 and it has been reported that more than 80% of admissions from the nursery 
to the neonatal intensive care unit in Japan are due to hypoglycemia or apnea155. However, it 
has been reported that hypoglycaemic episodes decrease with age156.  The few studies 
carried out in Africa have reported a high prevalence of severe hypoglycemia (25% - 
55%)157,158 which can be attributed to a lack of awareness among family members and 
healthcare workers and in most cases lack of blood glucose monitoring at an individual or 
hospital level.  
 
Diabetic Nephropathy.  
Diabetic nephropathy is persistent proteinuria in people who do not have urinary tract 
infection or any other disease that can be causing the proteinuria. Elevated plasma glucose 
levels play a significant role in the development of diabetic nephropathy159, given the fact 
that it positively regulates the expression of a transforming growth factor-β which is 
involved in the early stages of the disease. Despite, a decline in the incidence of 
complications being reported in many areas with specialized diabetes clinics160,161, diabetic 
nephropathy remains a major cause of morbidity and mortality among youths with T1D161. 
The cumulative prevalence of microalbuminuria (a marker of future renal failure) in 
childhood onset of T1D is between 25.7% – 50.7% after 10 – 19 years of diabetes162, with 
rates varying between 50% – 80% across different studies142, 162,163 164. However, studies by 
Finne et al.166 have shown a decline in the rate of progression to advanced nephropathy. 
Among children with type 1 diabetes in sub-Saharan Africa, very little is known with 
regards to the epidemiology of chronic kidney disease (CKD). Nevertheless, the available 
data in the region is mostly on adults indicating an overall prevalence of 13.9%167. In 
addition, there seem to be no significant difference in chronic kidney disease prevalence 
between the urban (12.4%) and rural (16.5%) settings. However, microalbuminuria which is 
a marker of nephropathy among adult type 2 diabetic patients in Cameroon was found to be 
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53.1%168, whereas, the prevalence of microalbuminuria in type 1 diabetic children was 
estimated at 29.3% in Tanzania126. 
Diabetic nephropathy remains a complication associated with generalized microvascular169 
and macrovascular170 damage, and in those with type 1 diabetes onset under the age of 20 
years, it increases mortality171.  Therefore, it is important to carefully monitor all children 
with T1D to ensure diabetes control is optimized and to look for evidence of early renal 
disease, given the fact that persistent microalbuminuria is predictive of later development of 
renal failure in T1D patients172.  
 
Diabetic retinopathy and neuropathy. 
Diabetic retinopathy is the most common cause of acquired blindness in the world, with a 
prevalence rate of about 20% – 25% in type 1 diabetics173. Retinopathy and neuropathy are 
unlikely to develop before the age of 15 and in patients with less than 5 years of diabetes 
duration174. An epidemiological study has shown that there exist a close relationship 
between diabetic nephropathy and retinopathy175. Although, diabetic neuropathy is rarely 
reported in children, screening is recommended for the other microvascular complications.  
In Cameroon, diabetic retinopathy in adults with type 2 diabetes was estimated to be 
40.3%176. However, this study finding cannot be generalized for all the patients with type 2 
diabetes in the country because, the study was carried out in an urban setting excluding 
diabetic patients living in the rural areas and those of low socioeconomic status. Also, 
Majaliwa et al.126 reported a prevalence of diabetic retinopathy of 22.68% among children 
and adolescents in Tanzania with a higher frequency being found in the age group before 
puberty.  
 
Macrovascular complications.  
Children with type 1 diabetes have a 10-fold higher risk of developing cardiovascular 
disease compared to individuals without diabetes174. Cardiovascular disease risk factors in 
childhood include the presence of obesity, smoking, microvascular complications, 
dyslipidemia, hypertension and a family history of premature cardiovascular disease177, 178. 
In addition, the presence of cardiovascular risk factors in children has also been shown to be 
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associated with accelerated atherosclerosis179,180. The increasing prevalence of obesity 
globally has also affected children with T1D and has led to a rise in the associated risk 
factors for macrovascular disease181, 182. Previous research in a Dutch cohort of 283 children 
age 3-18 years with a mean duration of diabetes of 5.3 years, reported that 38.5% of the 
children were overweight or obese, 13.1% hypertensive and 17.3% found to have elevated 
LDL cholesterol183. Similarly, one or two cardiovascular risk factors have been reported 
among children with type 1 diabetes in other studies184, 185.  
Epidemiological data on chronic complications of diabetes in the African region is limited186 
with cardiovascular disease complications related to diabetes also thought to be rare but they 
are currently on the rise187. A study by Tamba et al.188 in 2013 among adult diabetics in 
Cameroon reported the prevalence of coronary heart disease to be 23.6%. However, the 
authors indicated that the results might have been influenced given the retrospective nature 
of the study and lack of recommended tools for the proper diagnosis of diabetes 
complications. Therefore, in children and young adults with T1D, early detection and proper 
management of cardiovascular risk factors is very important. For example, the 
Epidemiology of Diabetes Interventions and Complications study (EDIC), a follow up study 
of the DCCT, showed that intensive insulin treatment decreased long-term macrovascular 
complications in T1D patients189. 
 
1.4. Predictors/determinants of treatment outcome as measured by glycaemic 
control. 
Given the benefits of strict glycaemic control, a study had described potential factors 
(demographic and diabetes-related characteristics) in children and adolescents with type 1 
diabetes associated with better glycaemic control190 and these factors differ between children 
and adults. However, these factors have been identified in developed countries and it is 
unclear whether the same or other factors determine glucose control in settings with very 
limited health resources. This is especially important because there is improved glycaemic 
control in children with type 1 diabetes in industrialized countries while it seems not to be 
improving in sub-Saharan Africa125,126,127,128. Some of the factors predictive of a patient’s 
glycosylated haemoglobin (HbA1c) level are discussed in the following paragraphs: 
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1.4.1. Age and diabetes duration.  
The age of the patient, age at onset and duration of diabetes have been shown to be 
significantly associated with the level of glycosylated haemoglobin of children with type 1 
diabetes119,191,192. Studies in the UK and France193 have shown that older age and longer 
duration of diabetes are associated with poor glycaemic control. A study among type 1 
diabetics in Wales194 to identify factors associated with glycaemic control reported that 
glycaemic control was worse among older children compared to the younger ones. 
Similarly, a study involving 2,218 pediatric patients with type 1 diabetes in the USA 
indicated that older age at onset was a risk factor for poor glycaemic control192. On the 
contrary, age was not associated with poor glycaemic control in studies from Australia and 
New Zealand195,196.   
Studies have also demonstrated that glycaemic control gets worse with increasing duration 
of diabetes192,197. However, a study in Sudan showed an inverse relationship128. 
 
1.4.2. Socioeconomic status (SES). 
Socioeconomic status (SES) usually defined as occupation, educational level, and household 
income has become an important determinant of glucose control among type 1 diabetics 
189,198,199
. Recent studies have associated socioeconomic variables such as family income, 
level of maternal education and family structure119,195,200 with glycaemic control among 
children with type 1 diabetes. Also, McKinney and colleagues193 observed that patients from 
deprived areas had poorer glycaemic control compared to those from affluent areas. In 
addition, studies in the USA and France have reported better glycaemic control among 
children from high socioeconomic backgrounds197, 201. However, that was not the case in 
Egypt202.   
Moreover, a study from the German Health Interview and Examination Survey for Children 
and Adolescents (KiGGS) among youths with type 1 diabetes found glycaemic control to be 
significantly associated with SES203.  
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1.4.3. Family living arrangements. 
Family living arrangements has also been found to be an important predictor of glucose 
control in children and adolescents with type 1 diabetes. Some studies have shown better 
glucose control among children/adolescents who live with both biological parents compared 
to children who came from single parent families200,204.  
Similarly, Thompson et al.205 found a 1.2% higher HbA1c in children from single mother 
families compared to those from two parent families. The authors attributed this to the lower 
income status and educational level of single mothers.  
 
1.4.4. Family involvement in diabetes-related tasks. 
The family environment where parents and guardians are actively involved in caring for 
children and adolescents with type 1 diabetes has been found to be associated with improved 
glycaemic control among patients206. In addition, family support and involvement of 
parents/guardians in the diabetes-related tasks of their children has been found to promote 
adherence and a better glycaemic control.  
For instance, a study by Anderson et al.207 found that more parental involvement in blood 
glucose monitoring (BGM) improved adherence and this translated to a better outcome. 
Also, Pereira et al.208 in Portugal found that support for female diabetics and those of the 
lower social class resulted in higher adherence and better metabolic control while family 
conflict in patients of the upper social class predicted poor glycaemic control. In addition, a 
recent meta-analysis by Tsiouli et al.209 demonstrated that family involvement in the 
treatment of young patients with type 1 diabetes resulted in improved glycaemic control, 
while family conflict was negatively correlated with the glycaemic control of the patient.   
 
1.4.5. Gender. 
Glycaemic control has been shown to differ across gender with females more likely to be 
poorly controlled than males191,202.  In a multicentre study from Austria and Germany 
(involving 27,035 participants), girls on average had a higher mean HbA1c than boys127. 
Also, in a study by Cutfield et al.200 in the Auckland region a significant association between 
gender and glycaemic control was reported with females exhibiting worse glycaemic control 
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compared to males. Similarly, gender was significantly associated with glycaemic control in 
a study from Egypt202. This Egyptian study indicated a high percentage of poor glucose 
control among girls older than 15 years compared to boys of the same age group. 
 
1.4.6. Regularity of clinic visits. 
The number of clinic attendance has been found to be predictive of a patient’s glycaemic 
control with fewer clinic visits being significantly associated with poorer control in 
children/adolescents followed up at diabetes centers210,211,212. However, studies in Tanzania 
and Portland 126,212 did not find any association between increased frequency of clinic 
attendance and glycaemic control.  
 
1.4.7. Insulin dose. 
The dose of insulin has also been found to be associated with the level of glycosylated 
haemoglobin. A higher dose of insulin per kg body weight has been found to be associated 
with poor glycaemic control in studies from France, New Zealand and Australia195,196,198.  
However, a study in Sudan demonstrated no difference in glycaemic control with a higher 
dose of insulin128. 
 
1.4.8. Adherence to treatment regimens. 
Adherence to the different treatment regimens represents an important factor in determining 
good glycaemic control and eventually a better treatment outcome.  A recent meta-analysis 
by Hood et al.121 demonstrated a negative correlation between adherence and HbA1c levels 
in children and adolescents with type 1 diabetes and this was observed to be independent of 
sociodemographic and other diabetes specific variables. Mehta et al.213 demonstrated that 
greater adherence to diet was associated with lower HbA1c levels in youth with diabetes. 
Nevertheless, the cross-sectional design of the study limits the ability to establish causal 
relationships between dietary adherence and HbA1c.  
In addition, blood glucose monitoring adherence has also been found to be predictive of 
glycaemic control among children with type 1 diabetes with less frequent blood glucose 
monitoring resulting in poor glycaemic control134,192,193.  Further, a study in Denmark 
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showed that glycaemic control improved with more frequent self-monitoring of blood 
glucose123. Similar results were reported in a study involving 26,723 children and 
adolescents aged 0-18 years with type 1 diabetes from 233 centers in Germany and 
Austria132. This finding was also confirmed in Sudan135.  
 
1.4.9. Primary caregiver. 
The primary caregiver involved in the care of children with type 1 diabetes is an important 
predictor of the glycosylated haemoglobin level of the patient. Several studies214,215,216 have 
indicated that the mother is most often the primary caregiver involved in the care of the 
diabetic child. Parental education and the active involvement of parents in the child’s 
diabetes self-management are crucial elements in achieving good glucose control. Al-
Odayani et al.214 found that type 1 diabetic children of mothers with higher level of 
education and more knowledge of diabetes irrespective of SES were better controlled 
resulting in a decrease in acute and chronic complications of diabetes in these children. 
 
1.4.10.  Caregiver diabetes knowledge and literacy. 
Diabetes knowledge of the family/caregiver plays an important role in improving the 
glycaemic control of children with type 1 diabetes. Evidence has shown that 
parents/caregivers/mothers with more knowledge of diabetes and better education results in 
lower HbA1c levels of their children214,216,217,218. Also, the attitude of parents and caregivers 
towards the care of children with diabetes has been found to be predictive of glycosylated 
haemoglobin levels196. For example, a study by Butler et al.119 to identify modifiable family 
factors that influence glycaemic control in youth with type 1 diabetes beyond the 
environment found that higher parental diabetes-specific knowledge and less parental-
perceived burden towards the care of diabetic children were predictive of HbA1c levels.  In 
addition, Soheilipour et al.219 found that disease awareness of mothers of type 1 diabetic 
children results in improved blood sugar control. Moreover, a study by Hassan and 
Heptulla220 found that literacy and numerical skills of caregivers influences significantly the 
glycaemic control of children with type 1 diabetes. Nonetheless, the voluntary nature of the 
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study might have excluded the less educated who often are unlikely to access outpatient care 
and have a sense of shame as a result of their illiteracy.  
In contrast to the above, an Indian study by Vimalavathini and colleagues221 observed that 
planned educational intervention programs on the attitudes, knowledge, and practices of type 
1 diabetics resulted in a significant improvement in the knowledge and attitude but no 
improvement in HbA1c levels.  Therefore, assessing literacy/numeracy skills of caregivers 
and addressing any deficiencies may be crucial in optimizing glycaemic control among 
children with type 1 diabetes. 
 
1.5. Challenges in diabetes management.  
Effective diabetes management requires a complex and demanding balancing of insulin 
dosing, exercise and diet alongside with frequent blood glucose monitoring which can be 
very challenging even to the most motivated patient. In the industrialized nations, enormous 
efforts have been made to manage type 1 diabetes and reduce chronic complications of the 
disease, while in many developing countries, there is limited clinical and metabolic data on 
the disease in children making its management even more difficult126. Despite advances in 
insulin therapeutics, adherence to diabetes regimens is often very difficult for patients of all 
ages especially adolescents122,222.  This is due to the fact that they undergo physiological 
changes during adolescence years causing greater insulin resistance and making it difficult 
for them to achieve and maintain the target glycaemic level116.  
Given the poor health seeking behaviour in developing countries and lack of quality health 
care,  most children present late resulting in a majority of children dying early due to 
complications223. Also, some of the major challenges to type 1 diabetes management in sub-
Saharan Africa include; missed and delayed diagnosis as well as insulin unavailability224 as 
opposed to developed countries. For instance, a Sudanese study reported that about 10% of 
children were not admitted at the time of diagnosis but were only admitted after they had 
developed DKA81. Another difficulty among children with type 1 diabetes in sub-Saharan 
Africa and other low income countries is that most of the children with diabetes are treated 
by an adult diabetic endocrinologist. This results in marked deficiencies in providing 
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information to children with diabetes and members of their families on the management of 
the disease.  
In addition, the cost of management of the disease is very high in developing countries 
where a majority of the population is living below the poverty line. Also, traditional healers 
are an integral part of most healthcare systems in some African and other less developed 
countries225 and some patients often visit the local traditional healers before coming to the 
hospital226. Traditional medicine or alternative medicine refers to health practices or 
approaches, beliefs and knowledge of incorporating animal, plant as well as mineral based 
medicines and spiritual therapies in combination to diagnose, treat, and prevent illnesses223. 
 
1.6. The situation in Cameroon.  
In Cameroon, there is a low prevalence of type 1 diabetes among children, partly due to the 
fact that most of the cases are not diagnosed and only a few of the children diagnosed live 
long enough after diagnosis given the poor prognosis associated with the disease.  As of 
2014, there was no data on the number of children living with type 1 diabetes in 
Cameroon14. The most reliable information comes from the program "Changing Diabetes in 
Children" (CDiC), a partnership initiative with Novo Nordisk and the local governments of 
some low-and-middle income countries which aims at improving on the capacity of the 
healthcare personnel and the healthcare system for the proper management and early 
diagnosis of T1D in children64. The CDiC program has been set up in 8 out of the 10 
administrative regions of the country and a diabetic register for prospective follow-up of 
patients aged 0 to 18 years has been established since 2010. As of November 2014, figures 
from the Cameroon Diabetic Association indicated that a total of 336 children with type 1 
diabetes are enrolled in the CDiC program. So far, 6 children have died, one from the 
Littoral and 5 from the North West Region. Therefore, the identification of factors 
associated with the outcome of patients in our setting is essential in order to establish 
appropriate interventions to prevent chronic complications and those at risk of acute 
complications. 
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Also, Cameroon still has a limited number of pediatric endocrinologists that can give 
informed advice on the management of the disease to these children and their 
parents/caregivers. There is therefore a need for the medical schools in the country to start 
offering specialist programmes in pediatrics to help prospective health professionals to 
acquire the necessary skills required for early diagnosis and adequate management of type 1 
diabetes among children in the country. 
 
1.7. Statement of the problem.  
Like the rest of the world, most countries in sub-Saharan Africa (SSA) are also having 
children suffering from type 1 diabetes which is associated with a high mortality rate and 
mostly the poor are being affected by the disease64,67. In contrast to Western countries, type 
1 diabetes is associated with a very poor prognosis in sub-Saharan Africa with many patients 
not being diagnosed and those diagnosed having a dramatically reduced life expectancy 
(usually less than one year)64,82. In addition, this disorder was thought to be rare in rural 
Africa65. Moreover, there are many barriers to appropriate diabetes care for children living 
with diabetes in the region such as inadequate healthcare systems, lack of trained health 
personnel and inability of the patient or family to afford treatment (i.e. insulin, syringes and 
blood glucose monitoring equipment). Despite the fact that type 1 diabetes is a treatable 
disease, it is associated with a poor prognosis in Cameroon.   
In Cameroon, information on factors associated to the outcome of children living with type 1 
diabetes is limited. If efforts are not made to understand the contributing factors to  good or 
poor glucose control, the number of children affected will keep increasing and this will lead 
to an increase in the number of families affected posing an emotional and financial burden 
on them. Also, it will affect the sustainability of the fragile healthcare system which is 
already overburdened with communicable diseases. In Cameroon, the CDiC program has 
helped in increasing access to care for children suffering from type 1 diabetes64 thereby 
improving on the health status and the quality of life of these children. According to the 
International Diabetes Federation14, over half a million children below the age of 14 are 
estimated to be living with type 1 diabetes with an estimated 46,400 of these children in the 
African region14. Despite the above evidence, there is no information on the prognosis of the 
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disease in Cameroon children.  In developed countries, a variety of factors that predict 
glucose control in children with type 1 diabetes has been documented125,187,192 and it is 
unclear whether the same or other factors determine glucose control in settings with very 
limited health resources like Cameroon.  
This study was done to identify the factors (predictors) of good and poor glucose control in 
children and adolescents with type 1 diabetes included in the Cameroon childhood diabetes 
registry. The findings from this study will help to define strategies which will ultimately 
help to improve the prognosis of these children in Cameroon (and probably other countries 
of sub-Saharan Africa). Also, it will create valuable data for the healthcare system of 
Cameroon and guide targeted interventions. In addition, it will help the responsible persons 
of the registry to adjust their approaches and thus hopefully result in good outcome for more 
children. 
 
1.8. Objectives of the study. 
Type 1 diabetes mostly affects children67 and its management remains a challenge to many 
sub-Saharan African families having a child with type 1 diabetes. Despite the fact that type 1 
diabetes is a treatable disease, it is still associated with a poor prognosis in Cameroon. 
Factors that predict the outcome of children with type 1 diabetes have been identified from 
studies in developed economies and it remains uncertain whether these predictors contribute 
to the same extent in predicting glucose control in a setting with inadequate health resources 
like Cameroon. This is particularly important as there seem to be improved glycaemic 
control in children with type 1 diabetes in the developed countries125,127, while it is not 
improving in sub-Saharan Africa126,128.  
This study therefore set out to identify the factors that predict good glucose control in 
children and adolescents with type 1 diabetes in the North West Region of Cameroon.  
Specifically, this study: 
• Determined the mean glycaemic control of the study population by age of patient and 
duration of diabetes.  
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• Examined the relationship between socio-demographic factors and diabetes-related 
factors on glucose control of children and adolescents with type 1 diabetes. 
• Investigated the clinical and biochemical characteristics at onset of type 1 diabetes, 
the study period as well as gender and age group specific differences in clinical and 
biochemical characteristics. 
• Investigated the impact of type 1 diabetes on the daily life of children and 
adolescents and its impact on glycaemic control. 
• Determined the frequency of diabetic ketoacidosis at type 1 diabetes onset and the 
potential factors associated with DKA in newly diagnosed children with type 1 
diabetes. 
 
This study was designed to collect and statistically analyze information (predictors) to find 
out whether variables can be identified which predict why the course of the disease is better 
in some cases than in others. The measures of interest include sociodemographic 
characteristics, diabetes knowledge of the children, practices of patient/caregiver related to 
diabetes, insulin availability, the impact of type 1 diabetes on daily life as well as 
clinical/biochemical parameters. 
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2. METHODS 
2.1. Study design/ population. 
 This study was a hospital based cross-sectional study, of data collected between January 
and August 2014, involving all the children and adolescents aged 0 to 18 years attending the 
clinics for children and adolescents living with diabetes in the North West Region of 
Cameroon. These clinics are specifically designed for the monitoring and appropriate 
treatment of these children. In addition, these clinics aim at educating the patients and their 
families on how to achieve the best possible glucose control. 
The prospective registration of laboratory and clinical data at diagnosis as part of the 
Cameroon childhood diabetes register had started since 2010. Type 1 diabetes was defined 
according to WHO criteria based on a clinical diagnosis106 by a physician with the date of 
onset being the date of diagnosis. A total of 76 children (35 boys and 41 girls) were involved 
in the study. Also, more than 60% of the study participants were from a rural setting and of 
low SES.  
 
2.2. Study area and the management of patients. 
This study was carried out in the children’s diabetic outpatient clinics in the North West 
Region of Cameroon including; the Bamenda Regional Hospital and the Banso Baptist 
Hospital - Kumbo.  
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Figure 2.1: Map of Cameroon indicating the study area (North West Region).  
Source: http://commons.wikimedia.org/wiki/Atlas_of_Cameroon  
 
The North West Region is the third most populated region in Cameroon with Bamenda 
being the capital. The region is one of the two English speaking regions of Cameroon and 
Bamenda is one of the major towns including other smaller towns like Kumbo. Also, as of 
North West 
Region 
36 
 
2010, this region had an estimated population of 1.8 million227 with a population density of 
104.3 people /km2. In addition, this region is also known for its academic activities including 
both English and French-speaking Cameroonians and currently has four universities (1 state 
university and 3 private universities). Cameroon like the rest of sub-Saharan African 
countries has been experiencing the epidemiological transition, and in 2002, Pasquet and 
colleagues228 indicated that Cameroon has the highest urbanization rate in sub-Saharan 
Africa. It has been predicted that the rate of urbanization will reach 67% by 2025. The North 
West Region is no exception to this rapid urbanization process. 
 
The pattern of food consumption follows three meals a day including breakfast, lunch and 
supper. In rural settings, the same food can be consumed during the three meals of the day 
with most of the staple food consumed during meals generally comprising of a starch 
component with either vegetables or soup with meat or fish depending on the SES of the 
family. In both the rural and urban areas of this region, occupations range from farming 
activities to businesses activities, white-collar jobs as well as students.  
 
The main public hospital for the region is the Bamenda Regional Hospital and other private 
and faith-based hospitals such as the Banso Baptist Hospital, the Mbingo Baptist Hospital 
and the St. Elizabeth Catholic General Hospital, Shisong which increase access to healthcare 
in the region. The Bamenda Regional Hospital is located in the city’s capital Bamenda and it 
remains the main epicentre for health in the region. Also, it serves as a referral hospital and 
provides health services to the more than 550,000 inhabitants of the Bamenda town and the 
entire population of the North West Region. The administration of the hospital is led by a 
director who in turn has several subordinates. Information from the Regional Delegation for 
Public Health for the North West Region indicates that the hospital has about 400 beds with 
about 350 trained health personnel and close to 49 ward assistants. Also, the hospital has 
over 21 departments located in one area of the hospital and 10 wards occupying another 
area. Access to the different hospital buildings is easy since the buildings are interconnected. 
Moreover, most of the buildings in the hospital are German style given the fact that 
Cameroon was initially a German colony. In addition, the Banso Baptist Hospital is the 
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oldest and one of the largest hospitals of the Cameroon Baptist Convention Health Board 
and it provides services to more than 100,000 patients annually. It is a 238 bed facility and 
the staff includes 5 physicians, an ophthalmologist, 2 surgeons, a Palliative Care physician 
and a dentist.  
 
 
Figure 2.2: Map of the North West Region indicating the 7 divisions and the study sites 
(adapted and modified from http://en.wikipedia.org/wiki/Northwest_Region_(Cameroon).  
 
The patients in these clinics are managed by a team of 2 diabetic nurses, 1 pediatrician and 2 
support staffs. As of November 2014, the number of children and adolescents up to 18 years 
with type 1 diabetes registered in these clinics was 80. These clinics run once every week. 
At diagnosis data on, height, weight, baseline lipid profiles, HbA1c, urine dipstick, blood 
glucose and ophthalmologic examinations are done for all the patients.  These children are 
reviewed at least once every three months by the diabetic nurse in charge of the clinic who 
also communicates with the physician in charge of the children regarding clinical care 
 
Banso Baptist Hospital 
 
 Bamenda Regional Hospital 
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issues. The diabetic nurse also follows-up on children who have missed their appointments 
by phone calls and identifies individual needs of the patients. HbA1c levels are monitored 
quarterly, while lipid profiles, serum creatinine, ophthalmologic examinations and thyroid 
function tests are repeated yearly. During subsequent clinic visits, height, weight, systolic 
and diastolic blood pressure, foot examinations and glucometer readings are reviewed.  
On the first day to the clinic, patients and guardians are given diabetes education and advice 
on appropriate nutrition. The components of the nutrition guidelines include; 
• Meal frequency which included 3 main meals and 3 snacks per day. 
• Meal content which should include carbohydrates, proteins and vitamins which may 
be consumed with a reduction in the amount of carbohydrate to two thirds of the 
usual amount but an increase in vegetable consumption. In addition, fruits may be 
consumed but only a portion. 
• Forbidden foods which included soft drinks, added sugar and animal fat.  
 
In addition, all patients attending these clinics are provided with insulin at no cost through 
the International Diabetes Federation (IDF), “Changing Diabetes in Children” (CDiC) 
program. Also, they are provided with blood glucose monitors, glucose strips, and diaries for 
measuring and recording of their blood glucose at home. These children/adolescents are 
encouraged to monitor their glucose level at least 3 or 4 times a day and record the 
information in their diaries. The blood glucose levels are then used by the clinicians to alter 
appropriately the insulin regimen. The patients are either on a 2 daily insulin injection 
regimen or on a multiple insulin injection regimen. 
A written consent that explained the purpose of the study was distributed to 
parents/guardians of the study participants and the heads of the clinics. Also, the research 
staff had to explain the purpose of the study to the participants before data collection. Those 
who consented to the study were asked to sign the consent form and assent was obtained 
from children above 10 years of age.   
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Inclusion criteria: 
This study included children and adolescents up to 18 years inclusive, with type 1 diabetes 
and attending the clinics for children living with diabetes in the North West Region of 
Cameroon. Also, informed consent was obtained from parents/guardians or assent from 
adolescents. 
 
2.3. Sample and sample size estimation. 
The sampling technique used in this study was convenient sampling since the children 
involved are in an intervention program currently going on in the country. 
The main aim of this study was to identify factors which predict good glucose control 
among children with type 1 diabetes using binary logistic regression as the main method of 
analysis.  The sample size for this study was estimated using Hsieh’s sample size 
formula/tables, which make use of binary logistic regression models with dichotomous 
covariates and a dichotomous dependent variable229. The main outcome variable (Y) in this 
study is HbA1c, which is an indicator of glucose control and it was assigned values of 0 for 
good glycaemic control and 1 for poor glycaemic control. An important covariate (X) in our 
study that is dichotomous is BGM adherence which was also assigned values of 0 and 1 for 
good BGM adherence and poor BGM adherence respectively. 
The Hsieh’s sample size formula used is below:  
                                     n   <    4P (1 – P) (Z1- α/2 + Z 1-β)2      
                                                  
                                                         (P1 – P2)2                        
 
Where P is probability of Y = 1, i.e. probability of having poor glycaemic control, which 
was equal to 0.5, α is significance level (0.05), 1 – β is power (80%), (Z1- α/2 + Z 1-β)2 is 7.84,  
P1 is the proportion of subjects with poor glucose control among those with good adherence 
to BGM (i.e. proportion at X = 0), P2 is the proportion of subjects with poor glucose control 
among those with poor adherence to BGM (i.e. proportion at X = 1). 
Using the option with low odds ratios as indicated in Hsieh’s study229, P1 = 0.2 and P2 = 0.5.  
Substituting the above values in the formula will give: 
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  n <   4(0.5)(1 – 0.5) (7.84)     =   87.1 
    (0.2 – 0.5)2 
 
Therefore the number of subjects needed in the study is 87. In the multivariate analysis in 
this study, several covariates were included in the regression model. However, a study 
indicated that the number of covariates in a model does not influence the sample size230.  
Given the fact that there were not sufficient children in the 2 clinics, the target sample size 
for this study could not be attained. In addition, these clinics are the only outpatient centres 
for children living with diabetes in the North West Region. Therefore, all the 76 children 
and adolescents who were available at both clinics were recruited into the study after 
obtaining written informed consent and assent from the parent/guardian and those above 10 
years of age respectively. 
 
2.4. Data collection/ equipment. 
2.4.1. Structured questionnaire.  
The data used in this study was collected using a structured questionnaire (Appendix 1), 
which was piloted before the study. During a regularly scheduled clinic visit the research 
staff (LLN) (assisted by a nurse in each clinic) met with each child/adolescent and parent or 
caregiver and jointly completed the questionnaire for children less than 10 years. For those 
older than 10 years, the section on the questionnaire addressing knowledge on diabetes was 
administered separately to the child. The questionnaire was translated from English to 
French and back translated from French to English, and it contained the following sections: 
sociodemographic and background characteristics; knowledge of diabetes for 
children/adolescents and caregivers; diabetes related practices; impact of type 1 diabetes on 
daily life of these children as well as insulin availability. 
Sociodemographic and background information: This section included; age, gender, age 
at onset of type 1 diabetes, diabetes duration, insulin regimen, primary caregiver and 
caregiver’s level of education, family living arrangements, socioeconomic status, degree of 
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urbanization, family history of diabetes, health status at time of diagnosis and infections 
before diagnosis. 
• Age and diabetes duration were calculated from the date of birth and date of 
diagnosis of the disease. 
• In a household the primary caregiver was defined as the person in the family most 
involved in the care of the diabetic child.  
• Family living arrangement was categorized as follows; living with both parents, 
living with a single parent, living with a sibling and living with a family relative or 
an orphan. 
• Degree of urbanization was defined by the area of resident of the patient as follows; 
urban and rural. 
• Health status at time of diagnosis and infections before diagnosis were assessed by 
asking specific questions on the type of illnesses the child/adolescent suffered from 
before diagnosis. 
• Positive family history of diabetes was defined as having an immediate relative (i.e. 
of the first degree) with type 1 diabetes.  
• Socioeconomic status (SES): This was assessed using the Cameroon public service 
system of occupation classification and the civil servant categories A, B, and C were 
used to categorize patients into high, middle and low SES respectively231. Individuals 
not working in the public sector were also assigned to these categories based on their 
income or profession. This information was provided by the parents/caregivers of the 
patients. Each child was assigned to a socioeconomic status category based on the 
highest level of SES of either parent. Furthermore, parental level of education was 
also assessed as a measure of SES using the questionnaire and four categories were 
established: no formal education (no elementary education), primary (1 – 6 years of 
education), secondary (7 – 13 years of education) and higher education (greater than 
13 years of education). 
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Diabetes knowledge of children and adolescents and caregivers: This was assessed using 
the Michigan Diabetes Research and Training Center’s brief diabetes knowledge test232. 
This is a multiple choice questionnaire that was modified to be applicable to the Cameroon 
patient population. Out of the 23 questions, a total of 15 questions were used since the other 
8 were not applicable to our patient population and the results were scored based on the 
percentage of correct responses.  
Diabetes related practices: These included; insulin adherence, dietary adherence, blood 
glucose monitoring (BGM) adherence, family involvement in diabetes related activities 
(insulin injection and blood glucose monitoring), regularity of clinic visits and the method of 
insulin storage.  
Diabetes-related practices were self-reported by parents and/or children on the 
questionnaires. 
• Insulin adherence: Patient adherence to insulin was determined by the number of 
doses of insulin missed in the last one week before the study and it was graded as 
good – for those who never missed any dose, average – for those who missed 1 to 3 
doses in the last one week and poor – for those who missed more than 3 doses in the 
last one week. In addition, reasons for missing the insulin doses were recorded.  
 
• Dietary adherence: Patient adherence to diet was evaluated using a 24-hour dietary 
recall233 and it was graded using a score derived from the dietary guidelines given at 
the clinic based on meal frequency and meal content as follows:  
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Component Score 
Meal frequency 
• 3 meals and 3 snacks or 3 meals and 2 snacks 
• 3 meals and 1 snack 
• 3 meals only 
• Less than 3 meals 
 
4 
3 
2 
1 
Meal content (lunch and dinner) – each meal was scored separately and divided 
by 2. 
• All the components (i.e. containing proteins, carbohydrates and 
vegetables) 
• Containing carbohydrates and vegetables 
• Containing  carbohydrates and proteins 
• Containing only carbohydrates                                                             
 
 
4 
 
3 
2 
1 
Contra-indicated  foods: each time a forbidden food was consumed -1 
 
In the scoring process of meal content, each time a contra-indicated food (such as soft 
drinks, added sugar, animal fat) was consumed it was given a score of - 1.  A maximum 
score of 8 was obtained for dietary adherence; a score of less than 4, between 4 and 6, and 
greater than 6 were interpreted as poor, average and good respectively. 
 
• Blood glucose monitoring (BGM) adherence: This was classified according to 
Hood et al.121 and graded as good – for those who measured their blood glucose 3 or 
more times a day, average – for those who measured their blood glucose 1 – 2 times 
a day, and  poor – for those who measured their blood glucose less than once a day.  
• Family involvement in diabetes related activities: This was assessed by the degree 
of involvement of parents/caregivers in the administration of insulin and BGM. This 
was then graded as minimal, moderate and maximal involvement using a modified 
scale used in the study by Anderson et al.207.  
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Caregiver involvement in insulin injections was determined by the number of doses of 
insulin injections injected or supervised by the caregiver in the last 24 hours and it was 
graded as minimal - no caregiver participation, moderate - caregiver injected/supervised 
only half of the injections and maximal- caregiver gave all the injections.   
Also, caregiver involvement in BGM was determined by the degree of participation of the 
caregiver in the task of BGM was graded as minimal - no caregiver participation, moderate 
– caregiver reminded the child to check blood glucose, asked the child about the blood 
glucose level or entered the glucose level in the diary and maximal – caregiver sets up the 
meter or did the finger prick and registered the results in the diary.  
 
• Regularity of clinic visits was determined by the number of times the patient had 
attended the outpatient diabetic clinic in the last 6 months before the study. 
• Method of insulin storage in the last 3 months prior to the study was classified as 
refrigeration, a pot of sand/charcoal/cold water or storage at room temperature. 
Availability of insulin: This was evaluated by determining the frequency at which the 
patient has missed insulin supplies from the clinic in the last 3 months prior to the study and 
was then classified as: never missed, missed every month or once or twice in 3 months. In 
addition, the ability of the patients to purchase insulin in case it was not available at the 
clinic was also determined.  
 
Impact of type 1 diabetes on daily life: This was assessed by specific questions on diet 
restriction, cessation of school or missed school days, poor performance in school, depressed 
mood, social isolation, hindrance to participate in sports activities and positive impact. There 
was also free conversation with the patients and parent/caregiver in order to find out other 
impacts type 1 diabetes was having on the daily life of the children/adolescents.  
 
2.4.2. Data collection forms. 
The prospective registration of clinical and laboratory data at diagnosis as part of the 
childhood diabetes register in Cameroon had started since 2010. To investigate biochemical 
as well as clinical characteristics of type 1 diabetes at diagnosis and during the study period 
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and to determine the potential factors associated with diabetic ketoacidosis (DKA) in newly 
diagnosed children/adolescents, data collection forms were used. Information at diagnosis 
on date of birth, date of onset of the disease, family history of disease, circumstances leading 
to diagnosis, duration (number of days) of symptoms before diagnosis reported by the 
child/adolescent or observed by the parent, height, weight, blood pressure, blood glycaemia, 
HbA1c, insulin regimen, clinical evidence of diabetic ketoacidosis (DKA) and urine tests 
(ketonuria) were obtained from the hospital records of the patients. 
Also, data collection forms were used to obtain information on treatment adherence, acute 
and chronic complications, weight, height, blood pressure, blood glycaemia for the 
children/adolescents during the study. 
 
Clinical evidence of diabetic ketoacidosis was assessed by the presence or absence of 
functional signs (symptoms or complaints reported by the patient and/or caregiver) 
including; fever, weight loss, anorexia, polyuria, polydipsia, difficulty in breathing, diarrhea, 
nausea, vomiting, lack of energy, abdominal pains and pain or tingling in the lower limbs.  
 
2.4.3. Physical examinations.  
Height and weight of children/adolescents: Height and body weight were measured by the 
clinic nurses ensuring that standard protocols were respected. Height was measured to the 
nearest 0.1 cm using a portable stadiometer (Seca 213, Germany). The body weight of each 
patient was measured with the child/adolescent wearing light clothes and no shoes using a 
digital scale (Omron BF 511, Japan) to the nearest 0.1 kg in order to accurately determine 
the insulin dose per kilogram body weight. The body mass index (BMI) of each participant 
was then calculated234. 
 
2.4.4. Laboratory investigations. 
Diagnosis of diabetes was done based on the World Health Organization (WHO) criteria106. 
All clinical/biochemical data at diagnosis and during the study period was collected from the 
Cameroon childhood hospital records, which included: fasting blood glucose, HbA1c, urine 
dipstick examinations, systolic and diastolic blood pressure and insulin requirements. 
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2.4.4.1. Glycosylated haemoglobin (HbA1c). 
Glycaemic control was determined by the measurement of glycosylated hemoglobin levels. 
Its value reflects the average level of blood sugar in the previous 2 – 3 months and the 
higher the HbA1c level, the higher the blood sugar level. HbA1c levels were determined for 
all the children who participated in the study since it was part of the routine care in the 
clinic. HbA1c which was the outcome of interest was measured using a BIO-RAD in2itTM 
analyzer (UK), which makes use of a BIO-RAD A1c system test cartridge. The blood for 
this purpose was obtained by a finger prick using a sterile lancet after cleansing the area 
with 70% alcohol. Using a blood key, about 10 µl of blood was collected from the site of the 
prick which was then fitted into a BIO-RAD A1c system test cartridge. The cartridge was 
then placed into the BIO-RAD in2itTM analyzer and the automated results (% HbA1c) were 
displayed and read from the machine after a processing time of 10 minutes. This test makes 
use of boronate affinity chromatography to separate the glycosylated fraction of 
haemoglobin from the non-glycosylated fraction.  
Quality control to check the optical and operating system of the analyzer was done once a 
day before samples were tested using an in2it system check cartridge. 
 
2.4.4.2. Blood glycaemia (fasting blood glucose/ postprandial glucose). 
Blood glycaemia (fasting blood glucose and post prandial glucose) levels were measured 
using Accu-Chek Active Blood Glucose monitoring system (Germany). This is done by 
pricking the side of a fingertip using a lancing device and applying a drop of blood (1µl) 
onto the Accu-Chek Active test strip. After inserting the test strip into the glucometer, the 
automated (blood glucose in mg/dl) results are displayed after a processing time of 10 
seconds.  Also, this was part of the routine care in the clinic.    
 
2.4.4.3. Blood pressure. 
Blood pressure levels (i.e. systolic and diastolic blood pressure) were obtained from the 
children and adolescents using an automated device (Omron M3, Vietnam).  Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were measured two times at a 3 minute 
interval on the same day and it was part of the routine care in the clinic. The measurements 
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were taken with the participant sitting in a relaxed position with the arm resting and the 
palm facing upwards. The average of the 2 measurements was recorded. 
 
2.4.4.4. Urine tests. 
Keto-Diabur Test 5000 strips (an Accu-Chek product) were used to screen for the presence 
of ketones, albumin and glucose in urine. The urine was collected in a clean dry container 
and after dipping a test strip inside, the results are read after 10 seconds. 
 
2.5. Statistical analysis.  
Data analyses was done using SPSS for windows version 20.0. Continuous variables were 
being tested for normality using the Kolmogorov-Smirnov (K-S) test. The anthropometric 
variables (height, weight and BMI) were standardized for age and gender (Z scores) using 
the WHO AnthroPlus software. This package uses the WHO 2007 growth reference data235. 
Frequency distribution tables were being used to summarize the diabetes specific variables 
and sociodemographic characteristics of the children. The mean HbA1c was compared 
across diabetes specific characteristics and different treatment regimens using a parametric t-
test. Also, a paired t-test was used to compare the differences in means of clinical and 
biochemical parameters of patients at diagnosis and during the study period. Unequally 
distributed variables were analyzed using the non-parametric Mann-Whitney U test. The 
association between caregiver involvement in diabetes related tasks and patient adherence 
was tested using chi square test.  In addition, the mean diabetes knowledge score of the 
children was compared across the different age groups and diabetes duration using one-way 
analysis of variance test (1-way ANOVA). 
 
The study population was then divided into two groups of glycaemic control as measured by 
HbA1c (poor glycaemic control, HbA1c > 9.0% and good glycaemic control, HbA1c ≤ 
9%)122. The frequencies of poor glycaemic control by potential determinants were estimated 
and this was followed by calculation of odds ratios (OR) using a univariate binary logistic 
regression analysis. Further, a multivariate binary logistic regression analysis (adjusting for 
age and gender) using a stepwise forward technique was performed to determine the 
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independent predictors of glycaemic control using all the variables that were significant in 
the bivariate analysis. The relationship between HbA1c and the different determinants was 
demonstrated using binary logistic regression models.  
The mean clinical and biochemical characteristics of patients according to metabolic status 
(with and without DKA) at diagnosis were compared using a parametric t-test with 
unequally distributed parameters analyzed using the Mann-Whitney U test. The potential 
risk factors of DKA were calculated and this was followed by the estimation of their 
corresponding odds ratios (OR) using binary logistic regression analysis. Multivariate 
analysis was not carried out due to the fact that there was no significant potential risk factor 
of DKA in the bivariate analysis. 
 A p-value of 0.05 was considered to be statistical significant. 
 
2.6. Ethical considerations. 
 Ethical approval was obtained from the National Ethics Committee (NEC) of the Ministry 
of Public Health, Cameroon and the Cameroon Baptist Convention Health Board (CBCHB). 
Administrative clearance was obtained from the North West Regional Delegation for Public 
Health of Cameroon. Hospital clearances were also obtained from the Bamenda Regional 
Hospital and Banso Baptist Hospital.  
In addition, the purpose, study procedure and expected outcomes of this study were 
explained to the participants and their caregivers before data collection was done. Also, 
written informed consent was obtained from parents/caregivers and assent from adolescents. 
In addition, all the data collected from the patients was treated with confidentiality. Further, 
there was an opt out facility to enable those who were no longer willing to participate in the 
study to withdraw. 
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3. RESULTS  
3.1.      Main characteristics of the study population. 
This study included 76 children and adolescents (35 boys and 41 girls) and 73.7% had been 
living with diabetes for more than 2 years. Gender distribution in the first age tertile was 
almost equal, while there was unequal distribution of boys and girls in the other age tertiles. 
Table 3.1 shows the main characteristics of the study population. More than 50% of the 
study participants were females. The mean age at diabetes diagnosis was 15.1 (95% CI 14.4 
– 15.8) years with girls having a slightly higher mean age at diagnosis compared to boys 
(15.4 ±2.6 vs 14.8 ±3.7 years).  However, this was not statistically significant. The mean 
duration of diabetes for the study population was 3.8 (95% CI 3.1 – 4.5) years. Also, a 
majority of the study participants were living with both biological parents, had a mother as 
the primary caregiver and received three or more insulin injections daily. In addition, more 
than 80% of the patients were of low/middle socioeconomic status with a majority of them 
from the rural area. In addition, 2 patients said they had visited a herbalist for the treatment 
of diabetes. 
Further, more than 90% of the children and adolescents reported having a concomitant 
infection such as fever, body weakness or a cold at the time of diagnosis. 
From the questionnaire, information on sociodemographic characteristics, SES, caregiver 
involvement in diabetes related practices, availability of insulin, impact of diabetes on daily 
life and diabetes knowledge assessment of the children were provided by all study 
participants giving a response rate of 100%. It is important to point out that 4 children (1 
boy and 3 girls) died after data collection. 
3 of the children (2 girls and 1 boy) were reported to have died in their sleep and were 
suspected to have died after experiencing hypoglycaemic episodes in the night. In spite of 
the fact that these children tried to properly manage their blood sugar, they were known for 
having frequent episodes of extremely low blood sugar levels. The death of the other child 
(a girl) was unclear but she was suspected to have died of diabetic ketoacidosis. 
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Table 3.1: Descriptive characteristics of the study population, N [% (95% CI)].  
Variables N Frequency Mean (95%CI) % (95%CI) 
Age Tertiles    15.1 (14.4 – 15.8) 
     First tertile (4 – 14 years)    25 32.9 (23.4 – 44.1)   
     Second tertile (15 – 16 years)    25 32.9 (23.4 – 44.1)   
     Third tertile (> 16 years)    26 34.2 (24.5 – 45.4)   
Gender      
     Male 35 46.1 (35.3 – 57.2)   
     Female 41 53.9 (42.8 – 64.7)   
Body mass index (BMI) (kg/m2)    23.3 (22.1 – 24.5) 
     Underweight (< 18.5) 6 7.9 (3.7 – 16.2)   
     Normal (18.5 – 25.0) 52 68.4 (53.7 – 77.8)   
    Overweight + obese (> 25.0) 18 23.7 (15.5 – 34.4)   
Family structure      
     Both parents living together 46 60.5 (49.3 – 70.8)   
     Single parent 17 22.4 (14.5 – 32.9)   
     Not living with parents 8 10.5 (5.4 – 19.4)   
     Orphan  5 6.6 (2.8 – 14.5)   
Primary caregiver      
     Mother  45 59.2 (48.0 – 69.6)   
     Father 10 13.2 (7.3 – 22.6)   
     Sibling 9 11.8 (6.4 – 21.0)   
     Other 12 15.8 (9.3 – 25.6)   
Caregiver education      
     No formal education 16 21.1 (13.4 – 31.5)   
     Primary school 20 26.3 (17.7 – 37.2)   
     Secondary/High school 29 38.2 (28.1 – 49.4)   
     University 11 14.4 (8.3 – 24.1)   
Duration of diabetes (years)    3.8 (3.1 – 4.5) 
     < 2  20 26.3 (17.7 – 37.2)   
     2 – 5  37 48.7 (37.8 – 59.7)   
     ˃ 5  19 25.0 (23.4 – 44.1)   
Insulin Regimen      
     2 daily injection 31 40.8 (30.4 – 52.0)   
     Multiple daily injection 45 59.2 (48.0 – 69.6)   
Degree of urbanization      
     Urban 30 39.5 (29.3 – 50.7)   
     Rural 46 60.5 (49.3 – 70.8)   
Socioeconomic status      
     Low  53 69.7 (58.7 – 78.9)   
     Middle  9 11.8 (6.4 – 21.0)   
     High  14 18.4 (11.3 – 28.6)   
CI; confidence interval   
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In our study population, storage of insulin by patients was done by refrigeration (18.4%), a 
pot of charcoal/sand or cold water (51.3%) and the rest at room temperature (30.3%). 
However, glycaemic control in the group which stored insulin in a fridge (9.8%, 95% CI 8.1 
– 11.4) was not significantly different from those who stored their insulin in a pot of 
charcoal/sand or cold water (10.8%, 95% CI 9.9 – 11.8) (p = 0.265). Also, those patients 
who stored their insulin in a fridge appeared to have similar glycaemic control to those who 
stored their insulin at room temperature.  
 
Insulin was available to all the children and adolescents at the clinic through the CDiC 
program. Nonetheless, 14.5% of children and adolescents reported having missed their 
supply of insulin from the clinic at least once in the previous three months prior to the study. 
Also, 11.8% said they will be able to purchase insulin in case there was a delay in supply by 
the clinic. 
 
3.2. Clinical and biochemical characteristics at diagnosis and during the study 
period. 
Table 3.2 presents the differences in clinical and biochemical parameters of the study 
participants at diagnosis and during the study period.  There was a significant decrease in 
HbA1c from diagnosis (11.1%) to the study period (10.3%) (p = 0.011). 2.6% of the patients 
during the study period had a postprandial glucose level of > 600 mg/dl compared to 7.9% at 
diagnosis. However, no statistical significant difference was observed in the mean fasting 
blood glucose and mean diastolic blood pressure.  
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Table 3.2: Differences in clinical and biochemical parameters at diagnosis and during the 
study period. 
Variables 
 
At diagnosis Study Period p-value* Mean (95%CI) Mean (95%CI) 
Age (years) 15.1 (14.4 – 15.8) 18.9 (18.4 – 19.4) < 0.001 
Body mass index (kg/m2) 22.9 (21.5 – 24.3) 23.3 (22.1 – 24.5) 0.408 
BMI SDS+ 0.57 (-0.04 – 1.18) 0.29 (-0.07 – 0.65) 0.359 
Systolic blood pressure 
(mmHg) 
112.7 (109.8 – 115.6) 116.9 (113.9 – 119.9) 0.021 
Diastolic blood pressure 
(mmHg) 
68.4 (66.1 – 70.7) 70.8 (68.5 – 73.1) 0.079 
HbA1c (%) 11.1 (10.5 – 11.7) 10.3 (9.6 – 10.9) 0.011 
Fasting blood glucose (mg/dl) 184.2 (151.3 – 217.1) 169.8 (136.1 – 203.5) 0.493 
Post prandial glucose (mg/dl) 364.4 (330.8 – 398.0) 266.9 (236.1 – 297.8) < 0.001 
CI; confidence interval: *calculated using paired t-test. . +Based on WHO 2007 reference data. Mean height, 
weight and BMI SDSs included only children ≤ 19 years (n = 41). 
 
It is shown in table 3.3 that during the study period, children and adolescents in the third age 
tertile had a slightly lower mean HbA1c (9.8%, 95% CI, 9.1 – 10.5) compared to those in 
the first age tertile (10.8%, 95% CI, 10.2 – 11.4, p = 0.209). However, there was no 
significant linear trend for HbA1c to decrease with increasing age (p = 0.228). Also, there 
was no significant difference in the glycaemic control between boys and girls in the different 
age tertiles. 
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Table 3.3: Differences in clinical and biochemical data by age groups during the study 
period, [mean (95% CI)]. 
Variables 
Age tertiles 
First 
Mean (95% CI) 
Second 
Mean (95% CI) 
Third 
Mean (95% CI) p-value* 
Weight (kg) 56.5 
(54.1 – 58.9) 
61.3 
(57.4 – 65.2) 
67.4 
(64.0 – 70.8) 
0.029 
Weight SDS+ 
 
-0.50 
(-1.00 – 0.00) 
-0.88 
(-1.95 – 1.90) 
0.35 
(-0.83 – 1.53) 
0.146 
Height (cm) 159.1 
(157.2 – 160.9) 
160.6 
(158.7 – 162.5) 
166.1 
(163.9 – 168.2) 
0.073 
Height SDS+ 
 
-1.04 
(-1.54 – -0.55)  
-1.60 
(-2.48 – -0.73) 
-0.36 
(-1.31 – 0.60) 
0.072 
Body mass index (kg/m2) 21.7 
(21.0 – 22.4) 
23.9 
(22.2 – 25.6) 
24.3 
(23.3 – 25.3) 
0.165 
BMI SDS+ 
 
0.14 
(-0.37 – 0.64) 
0.23 
(-0.44 – 0.90) 
0.65 
(-0.33 – 1.64) 
0.514 
Systolic BP(mmHg) 117.5 
(114.5 – 120.5) 
117.1 
(113.8 – 120.4) 
116.9 
(114.4 – 119.4) 
0.985 
Diastolic BP (mmHg) 72.0 
(69.4 – 74.6) 
71.4 
(69.2 – 73.6) 
69.5 
(67.5 – 71.5) 
0.645 
HbA1c (%) 10.8 
(10.2 – 11.4) 
10.3 
(9.6 – 11.0) 
9.8 
(9.1 – 10.5) 
0.482 
Fasting blood glucose (mg/dl) 159.8 
(134.7 – 184.8) 
164.4 
(137.4 – 191.4) 
145.7 
(127.1 – 164.3) 
0.820 
Postprandial glucose (mg/dl) 268.3 
(239.3 – 297.3) 
251.8 
(222.6 – 280.9) 
277.9 
(250.6 – 305.1) 
0.760 
*calculated using one way ANOVA +Based on WHO 2007 reference data. Mean height, weight and BMI 
SDSs included only children ≤ 19 years (n = 41). 
 
The distribution of clinical symptoms reported by the patient or caregiver before diagnosis is 
shown in Figure 3.1. The most frequent symptom reported was polyuria and polydipsia and 
it was present in 63.2% of the study population. 13.2 % were reported to have coma or 
impaired consciousness during diagnosis, while 2.6% had weight loss. This figure shows 
that among type 1 diabetic children and adolescents in the North West Region of Cameroon, 
the frequency of polyuria and polydipsia outweighs the other clinical symptoms. Also, the 
mean duration of symptoms before diagnosis was 34.4 ± 28.5 days. 17.1% of the study 
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population had symptoms over 2 months, meanwhile 5.3% had duration of symptoms of ≤ 7 
days.  
In addition, ketonuria was found in 18.4% of the children during diagnosis. 24.2% of boys 
presented with ketonuria at diagnosis compared to 18.7% of girls.  Nevertheless, urine 
analysis at diagnosis was done only for 85.5% of the study population (33 boys and 32 
girls).  
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Figure 3.1: Clinical symptoms reported before diagnosis of type 1 diabetes. 
 
Less than 40% and 18.4% of the study population reported a positive family history of 
diabetes and hypertension respectively. Nevertheless, a positive family history of diabetes or 
hypertension did not influence glycaemic control in the children. Also, more than 40% of 
the children had not been hospitalized in the last 12 months prior to the study. In addition, 
28.9% were found to have experienced hypoglycaemic episodes in the last 3 months before 
the study with less than 4% of them being severe. In addition, more than 90% of the study 
population never had ketoacidosis in the last 12 months prior to the study.  
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The percentage of children reported to be suffering from diabetes complications such as foot 
ulcers, retinopathy and neuropathy was 2.6%, 7.9% and 1.3% respectively. That 
notwithstanding, there was no other chronic complication reported among the children. 
 
3.3. Comparison of clinical and biochemical characteristics of the study population 
according to gender. 
Table 3.4 depicts the differences in the biochemical and the clinical characteristics of the 
study population at diagnosis and during the study period by gender. There was no 
statistically significant difference observed in most of the clinical and biochemical 
parameters of the investigated population according to gender during the study period. 
However, the mean postprandial blood glucose level during the study period was observed 
to increase with increasing age in boys, a finding which was not found in girls. Nevertheless, 
it was not significant. Also, after adjusting for age, there was a significant difference in BMI 
SDS between boys and girls during the study period and its calculation was done only for 
45.7% of boys and 60.9% of girls. 
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Table 3.4: Differences in biochemical and clinical parameters at diagnosis and study period 
by gender, [mean (95% CI)]. 
 
Variables 
 
Boys 
N = 35 
Girls 
N = 41 P*-value 
Mean (95%CI) Mean (95%CI) 
At diagnosis      
      
Age (years) 14.8 (13.5 – 16.1) 15.4 (14.6 – 16.2) 0.417 
Body mass index (kg/m2) 21.2 (19.5 – 22.9) 24.2 (22.1 – 26.3) 0.033 
BMI  SDS+ 0.40 (-0.12 – 0.92) 0.90 (0.35 – 1.45) 0.183 
Systolic blood pressure 
(mmHg) 
113.6 (108.9 – 118.2) 111.9 (108.1 – 115.7) 0.575 
Diastolic blood pressure 
(mmHg) 
67.9 (63.9 – 71.8) 68.7 (66.1 – 71.3) 0.730 
HbA1c (%) 11.4 (10.4 – 12.4) 10.9 (10.1 – 11.7) 0.409 
Fasting blood glucose (mg/dl) 192.6 (136.5 – 246.7) 174.8 (138.4 – 211.2) 0.566 
Post prandial glucose (mg/dl) 411.3 (359.3 – 463.3) 329.3 (289.6 – 369.0) 0.013 
      
During study period      
      
Age (years) 19.3 (18.6 – 19.9) 18.7 (17.9 – 19.4) 0.237 
Body mass index (kg/m2) 22.0 (20.8 – 23.2) 24.4 (22.4 – 26.4) 0.050 
BMI SDS+ -0.18 (-0.65 – 0.29) 0.60 (0.11 – 1.09) 0.021 
Systolic blood pressure 
(mmHg) 
118.5 (113.9 – 123.1) 116.1 (112.3 – 119.7) 0.410 
Diastolic blood pressure 
(mmHg) 
71.8 (68.2 – 75.4) 70.3 (67.5 – 73.1) 0.517 
HbA1c (%) 10.8 (9.7 – 11.9) 9.9 (9.0 – 10.8) 0.228 
Fasting blood glucose (mg/dl) 153.5 (126.2 – 180.8) 160.1 (125.6 – 194.6) 0.791 
Post prandial glucose (mg/dl) 274.3 (232.3 – 316.3) 260.2 (222.2 – 298.2) 0.620 
Diabetes duration (years) 4.5 (3.2 – 5.8) 3.3 (2.5 – 4.1) 0.130 
CI; confidence interval, *p-value calculated using independent t-test; HbA1c, glycosylated haemoglobin. 
+Based on WHO 2007 reference data. Mean BMI SDS during study period included only participants ≤ 19 
years (16 boys and 25 girls). 
 
3.4. Glycosylated haemoglobin (HbA1c) by diabetes specific characteristics. 
The mean HbA1c of the study population was 10.3 ± 2.9% and only 23.7% of the children 
attained the ADA HbA1c target level of < 7.5%.  In addition, 17.1 % of children/adolescents 
had mean HbA1c of ≥ 14%. These findings confirm the fact that a majority of the children 
and adolescents in sub- Saharan Africa with type 1 diabetes are not adequately controlled. 
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Girls on average had a lower mean HbA1c (9.9 %, 95% CI 9.0 – 10.8) compared to boys 
(10.8%, 95% CI 9.7 – 11.9). However, this was not significant. Table 3.5 shows the 
diabetes-related characteristics by glycaemic control of the patients. 
 
Glycaemic control (HbA1c) was more likely to be better among children having a mother as 
a primary caregiver (8.7%, 95% CI 8.0 – 9.4) compared to those having a father, a sibling or 
another family member as caregiver (12.7%, 95% CI 11.9 – 13.4).  Also, there was no 
significant difference in glycaemic control between the different categories of diabetes 
duration, family living arrangements, patient’s educational level and family history of 
diabetes (p > 0.05).  
It was observed that 62.9% of patients being treated on 2 daily insulin injections had good 
glycaemic control compared to 37.1% of those on multiple daily insulin injections. In 
addition, more than 80% of the study participants who checked their blood glucose 3 or 
more times a day had good glycaemic control compared to 17.1% of those who had 2 or less 
blood glucose checks a day. Further, 58.3% of children with poor glycaemic control had a 
positive family history of diabetes. 
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Table 3.5: HbA1c of patients by specific diabetes characteristics, [mean (95% CI)]. 
Variable  HbA1c p-value* Mean 95%CI 
Age tertiles    
     First 10.8 (10.2 – 11.4)  
     Second 10.3 (9.6 – 11.0) 0.561 
    
     First 10.8 (10.2 – 11.4)  
     Third         9.8  (9.1 – 10.5) 0.209 
Duration of diabetes (years)    
     < 2  10.5 (9.1 – 11.9)  
     2 – 5  10.1 (9.1 – 11.1) 0.630 
    
     < 2  10.5 (9.1 – 11.9)  
     ˃ 5  10.5 (9.2 – 11.8) 0.924 
Insulin Regimen    
     2 daily injections 8.9 (7.9 – 9.9)  
     Multiple daily injection 11.2 (10.4 – 12.0) 0.001 
Family structure    
     Both parents living together 10.2 (9.3 – 11.1)  
     Others  10.4 (9.3 – 11.5) 0.771 
Primary caregiver    
     Mother 8.7 (8.0 – 9.4)  
     Others 12.7 (11.9 – 13.4) < 0.001 
Caregiver education    
     None/primary 9.9 (8.9 – 10.8)  
     Secondary/tertiary 10.7 (9.7 – 11.7) 0.273 
Clinic visits in the last 6 months    
       1 – 3 times 11.5 (10.7 – 12.3)  
       ˃ 3 times 8.7 (7.8 – 9.6)  < 0.001 
Family history of diabetes    
      Positive family history 10.5 (9.1 – 11.9)  
      No family history 10.2 (9.4 – 11.0)  0.654 
* Calculated using students’ independent t-test; CI confidence interval 
 
The mean diabetes knowledge score for adolescents was 65.4 ± 14.4% and it revealed an 
increasing linear trend with increasing diabetes duration. That notwithstanding, it was not 
significant. The results of diabetes knowledge assessment of adolescents are summarized on 
Table 3.6.  Also, the adolescent’s level of education had an influence on the diabetes 
knowledge score. Adolescents with no formal education as well as school dropouts had a 
lower mean score for the diabetes knowledge test compared to those who had attained a 
59 
 
certain level of education that was adequate for their age. In addition, all the adolescents had 
knowledge of the importance of HbA1c in the management of T1D. Nevertheless, 
knowledge of HbA1c did not influence glycaemic control. 
 
Table 3.6: Diabetes knowledge scores of adolescents with type 1 diabetes. 
Diabetes characteristics Score p-value* Mean (%) 95%CI 
Age tertiles    
     First 65.9 (62.1 – 69.7) 0.367 
     Second  62.2 (59.1 – 65.3)  
     Third 67.9 (64.9 – 70.8)  
Duration of diabetes    
     < 2 years 59.2 (51.6 – 66.7) 0.079 
     2 to 5 years 67.5 (63.5 – 71.6)  
     ˃ 5 years 67.7 (60.1 – 75.2)  
* Calculated using one way ANOVA 
 
3.5. Adherence to the different treatment regimens and caregiver involvement in 
diabetes related tasks 
Figure 3.2 indicates the frequency of adherence to the different treatment regimens.  Insulin 
adherence was good in less than 40% of the study population while poor adherence was 
observed in 22.4% of the study population. Also, adherence to BGM was good in more than 
half of the study participants. Adherence to the dietary regimen prescribed at the clinic was 
average in a majority (81.6%) of the patients. Also, it was realized that most adolescents had 
difficulties reducing the quantity of carbohydrates in the diet. 
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Figure 3.2: Treatment adherence in children and adolescents with type 1 diabetes. 
 
Table 3.7a shows adherence to the different treatment regimens by age tertiles. There was a 
significant association between BGM adherence by age tertiles (Chi-square value = 10.4, df 
= 4, p = 0.034), a finding that was not observed with insulin and dietary adherence.  
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Table 3.7a: Adherence to the different treatment regimens by age tertiles. 
 First tertile 
N = 25 
Second tertile 
N = 25 
Third tertile 
N = 26 
Total 
N = 76 p-value* 
N (%) n (%) n (%) n (%) 
Insulin          
     Good 8   32 11 44 7 26.9 26 34.2 0.324 
     Average 9   36  9 36 15 57.7 33 43.4  
     Poor 8   32 5    20 4 15.4 17 22.4  
          
Diet          
     Good 2 8 3 12 2 7.7 7 9.2 0.966 
     Average 21 84 20 80 21 80.8 62 81.6  
     Poor 2 8 2 8 3 11.5 7 9.2  
          
BGM          
     Good 18 72 14 56 11 42.3 43 56.6 0.034 
     Average 5 20 5 20 13 50 23 30.3  
     Poor 2 8 6 24 2 7.7 10 13.1  
* Calculated using Chi square 
 
Table 3.7b shows the differences in mean HbA1c by adherence to the different treatment 
regimens. Glycaemic control was significantly improved among children who had good 
adherence to insulin and BGM (p < 0.001). Also, the insulin regimen used (whether 2 daily 
insulin injections or multiple daily injections) by the children and adolescents did not have 
an effect on adherence (p > 0.05). 
 
Table 3.7b: Differences in treatment adherence and glycaemic control. 
Treatment 
adherence 
Mean HbA1c (95% CI) p-value* 
Good  Poor/Average  
Diet 11.0 (8.6 – 13.4) 10.2 (9.5 – 10.9) 0.506 
BGM  8.8 (7.9 – 9.6) 12.2 (11.5 – 12.9) < 0.001 
Insulin 8.8 (7.6 – 9.9) 11.1 (10.3 – 11.9) 0.001 
*Calculated using independent t-test.  
 
In addition, in this study it was observed that caregiver involvement in the diabetes-related 
tasks of the child varied with the type of task (Tables 3.8a and 3.8b). Maximal parental 
involvement in the task of BGM was observed in 88.4% of the children compared to 57.7% 
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in the task of insulin injection. Table 3.8a demonstrates that maximal caregiver involvement 
in the task of BGM was significantly associated with good patient adherence to BGM (Chi-
square = 44.5; df = 2; p < 0.001). However, no such relationship was observed in the task of 
insulin injection as indicated in Table 3.8b.  
 
Table 3.8a: Association between caregiver involvement in BGM and patient adherence to 
BGM. 
Involvement  
Adherence ratings Total 
p-value* Good 
N = 43 (%) 
Poor/Average 
N = 33 (%) N = 76 (%) 
BGM        
     Minimal 1 2.3 13 39.4 14 18.4 < 0.001 
     Moderate 4 9.3 16 48.5 20 26.3  
     Maximal 38 88.4 4 12.1 42 55.3  
*Calculated using Chi square test 
 
 
 
Table 3.8b: Association between caregiver involvement in insulin injection and patient 
adherence to insulin injection. 
Involvement  
Adherence ratings Total 
p-value* Good 
N = 26 (%) 
Poor/Average 
N = 50 (%) N = 76 (%) 
Insulin injection        
     Minimal 9 34.6 13 26.0 22 29.0 0.161 
     Moderate 2 7.7 13 26.0 15 19.7  
     Maximal 15 57.7 24 48.0 39 51.3  
*Calculated using Chi square test 
 
Among children in the first age tertile, 68% of caregivers had maximal involvement in BGM 
compared to 46.2% among those in the third age tertile (p = 0.270). Equivalent findings 
were also observed in the task of insulin injection, 52% versus 46.2% (p = 0.778) for those 
in the first and third age tertiles respectively.  
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3.6. Clinical and biochemical characteristics of patients according to metabolic 
status at diagnosis of type 1 diabetes.  
Table 3.9 shows the clinical and laboratory data of children according to metabolic status at 
diagnosis of type 1 diabetes. At diagnosis less than 30% of the children and adolescents had 
evidence of diabetic ketoacidosis (DKA) with a decreasing frequency with increasing age in 
males but not with females. On average more girls (34.1%) than boys (22.8%) presented 
with ketoacidosis at diagnosis. Nevertheless, the frequency of diabetic ketoacidosis was 
found to be almost the same among children and adolescents in all age tertiles.  
 
Table 3.9: Comparison of clinical and laboratory data of children according to metabolic 
status at diagnosis of type 1 diabetes. 
 
Clinical characteristic 
DKA 
N= 22 
No DKA 
N= 54 p-value 
Mean  95%CI Mean  95%CI 
Age (years) 15.1 (13.9 – 16.3) 15.2 (14.3 – 16.1) 0.898* 
Duration of symptoms (days)  45.2 (24.0 – 66.4) 30.1 (24.2 – 35.9) 0.163** 
Postprandial blood glucose (mg/dl) 388.2 (333.4 – 443.0) 354.4 (312.6 – 396.2) 0.359* 
Fasting blood glucose(mg/dl) 209.0 (149.4 – 268.6) 170.3 (145.4 – 195.2) 0.241* 
HbA1C at diagnosis (%) 12.1 (10.8 – 13.4) 10.7 (9.9 – 11.4)  0.045** 
BMI at diagnosis (kg/m2) 20.4 (18.7 – 22.1) 23.9 (22.1 – 25.7) 0.016* 
* Calculated using independent t-test: **calculated using Mann-Whitney U test: CI; Confidence interval; 
DKA,  Diabetic ketoacidosis 
 
 
3.7. The impact of type 1 diabetes on the daily life of children and adolescents 
Type 1 diabetes had different impacts on the daily life of children and adolescents. More 
than 60% reported that diabetes had an impact on their lives (Table 3.10). 3.9% of the 
children reported a positive impact on their daily life by making them more responsible 
while 72.4% said the disease had a negative impact on their life. This was much higher 
among adolescents > 15 years with more girls (68.4%) reporting negative impact compared 
to boys (48.8%). Dietary difficulties and poor school performance were the most common 
problems reported by the patients. There was no statistically significant difference in 
glycaemic control among children who reported a negative impact on their lives and those 
who had no impact.   
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Table 3.10: Impact of type 1 diabetes on daily life of children and adolescents. 
Impact  N % Mean HbA1c (%) Negative impact No impact p-value* 
Sports restriction 30 39.5 10.7 10.0 0.367 
Social isolation 30 39.5 10.4 10.2 0.759 
Unhappy mood 37 48.7 10.5 10.1 0.513 
Diet restriction 60 78.9 10.4 10.0 0.644 
Poor school performance 37 48.7 10.2 10.4 0.744 
Positive impact 3 3.9 - - - 
*Calculated using independent t-test 
 
3.8. Bivariate and multivariate analysis. 
Bivariate analysis (unadjusted associations between poor glycaemic control and individual 
factors) in Table 3.11a indicated that having a mother as the primary caregiver (OR 0.07, 
95% CI, 0.02 – 0.2), being on 2 daily insulin injections (OR 0.2, 95% CI, 0.1 – 0.5), good 
adherence to blood glucose monitoring (OR 0.1, 95% CI, 0.04 – 0.3) and good adherence to 
insulin injection (OR 0.3, 95% CI, 0.1 – 0.8) were significantly (p < 0.05) associated with 
good glucose control as indicated by HbA1c, while age (OR 1.1, 95% CI 0.4 – 3.2),  
diabetes duration (OR 0.9, 95% CI 0.3 – 2.9) and  socioeconomic status (OR 2.4, 95% CI 
0.9 – 6.5) did not show any significant association (p > 0.05) with glycaemic control.   
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Table 3.11a: Frequency and odds ratio for the association between poor glycaemic control 
and determinants (bivariate analysis). 
Determinants N Poor glycaemic control p-value Frequency OR 95% CI 
Age tertiles      
     Third (> 16 years) 26 50.0 1.1 (0.4 – 3.2) 0.886 
     Second (15 – 16 years) 25 52.0 1.5 (0.5 – 4.5) 0.474 
     First (4 – 14 years) 25 60.0 ref   
Diabetes duration (years)      
     >5  19 52.6 0.9 (0.3 – 2.9) 0.928 
     2 -  5   37 51.4 1.4 (0.4 – 4.8) 0. 643 
     < 2 20 60.0 ref   
Primary caregiver      
     Mothers 45 31.1 0.07 (0.02 – 0.2) < 0.001 
     Others 31 87.1 ref   
Insulin regimen      
     2 daily injection 45 21.9 0.2 (0.1 – 0.5) < 0.001 
     Multiple daily injection 31 71.1 ref   
Insulin adherence      
     Good 26 34.6 0.3 (0.1 – 0.8) 0.017 
     Poor/average 50 64.0 ref   
BGM adherence      
     Good 43 32.6 0.1 (0.04 – 0.3) < 0.001 
     Poor/average 33 81.8 ref   
Dietary adherence      
     Poor/average 69 52.2 2.3 (0.4 – 12.6) 0.341 
     Good 7 71.4 ref   
Caregiver involvement in insulin injection      
     Minimal/moderate 37 83.8 14.9 (4.8 – 46.5) < 0.001 
     Maximal 39 25.6 ref   
Caregiver involvement in BGM      
     Minimal/moderate 34 79.4 7.7 (2.7 – 22.0) < 0.001 
     Maximal 42 33.3 ref   
Clinic visits in the last 6 months      
      1 – 3 times 44 70.5 5.2 (1.9 – 14.1) 0.001 
       ˃ 3 times 32 31.3 ref.   
Socioeconomic status      
      Low/middle 53 60.4 2.4 (0.9 – 6.5)  0.091 
      High   23 39.1 ref.   
Degree of urbanization       
      Rural 46 60.0 1.5 (0.6 – 3.8) 0.394 
      Urban  30 50.0 ref.   
OR; odds ratio (unadjusted for age and gender): CI; confidence interval: BGM; blood glucose monitoring: Poor 
glycaemic control; HbA1c > 9.0% 
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Table 3.11b shows the results of the multivariate analysis which included only variables that 
were significant in the bivariate analysis. Multivariate analysis showed that having a mother 
as the primary caregiver (OR 0.02, 95% CI 0.002 - 0.189, p < 0.001) was significantly 
associated with good glucose control. Also, participants who had minimal/moderate 
caregiver involvement in the task of insulin injection had an increased risk of poor glucose 
control (OR 26.8, 95% CI 4.4 – 56.1, p < 0.001).  
 
Table 3.11b: Multivariate binary logistic regression analysis with HbA1c (%) as dependent 
variable, (odds ratios adjusted for age and gender). 
 
 
 
 
B Standard 
error 
Odds ratio 
(OR) (95% CI) p-value 
Primary caregiver 
Mother  
Others 
        -3.436 1.082  
0.02 
 
 
(0.002 – 0.189) 
ref. 
 
0.001 
 
Caregiver involvement in insulin 
injection 
Minimal/Moderate 
Optimal  
3.617    1.046  
 
   26.8 
 
 
 
(4.4 – 56.1) 
ref.  
 
 
0.001 
 
Constant  
 
1.795 
 
 1.557 
   
OR; odds ratio: CI; confidence interval 
 
Also, the results of the bivariate analysis to determine the risk factors for DKA at diagnosis 
demonstrated that the presence of ketonuria at diagnosis (OR 1.9, 95% CI 0.5 – 7.9), age 
(OR 0.8, 95% CI 0.2 – 2.6) and a positive family history of diabetes at diagnosis (OR 0.9, 
95% CI 0.3 – 2.9) did not show a significant association with DKA as shown on Table 
3.11c. 
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Table 3.11c: Frequency and odds ratio for the association between diabetic ketoacidosis and 
potential risk factors (bivariate analysis). 
 
Determinants N Diabetic ketoacidosis p-value Frequency OR 95%CI 
Age       
     First tertile 25 28.0 0.8 (0.2 – 2.6) 0.691 
     Second tertile 25 32.0 0.9 (0.3 – 3.2) 0.931 
     Third tertile 26 26.9 ref   
HbA1c      
     Poor outcome 41 59.1 1.3 (0.5 – 3.7) 0.566 
     Good outcome 35 40.9 ref   
Ketonuria      
     Yes 14 21.4 1.9 (0.5 – 7.9) 0.353 
     No 52 36.5 ref   
     Missing data 10     
Positive family history of diabetes      
     Yes 24 29.2 0.9 (0.3 – 2.9) 0.997 
     No 52 28.8 ref   
OR; odds ratio (adjusted for age and gender): CI; confidence interval. Ketonuria was done only for 65 children 
(33 boys and 32 girls).  
. 
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4. DISCUSSION 
4.1. Relationship between sociodemographic and diabetes related characteristics 
with glycaemic control. 
Achieving good glycaemic control is the cornerstone in the management of type 1 diabetes 
as it is essential for preventing short-term and long-term complications. However, the 
management of T1D in children and adolescents remains a challenge to the patient, their 
families and the healthcare provider. Current standards for management of the disease focus 
on optimizing glycaemic control in order to reduce the risks of short-term and long-term 
complications.  
This study sets out to identify the factors that predict good glucose control in children with 
type 1 diabetes in the North West Region of Cameroon. This study has demonstrated that 
having a mother as a primary caregiver is an important predictor of good glycaemic control 
among children with type 1 diabetes. Also, it was confirmed from the multivariate analysis 
that children with minimal/moderate caregiver involvement in the task of insulin injection 
were at risk of poor glucose control as measured by HbA1c. 
 
Our study found that the mean HbA1c of the study population was 10.3 ± 2.9% and that 
more than three-quaters (76.3%) of the patients in this study were not adequately controlled 
(HbA1c 
 > 7.5%), values similar to those obtained in Tanzania126 (10.65%), Sudan128 (9.3%) and 
Kenya236 (12.1%) but worse than values observed in the US199 (7.6%), Denmark125 (8.20%), 
Germany and Austria127 (7.8%) and Germany203 (8.7%).  However, there was a significant 
decrease in mean HbA1c from the time of diagnosis to the study period which is an 
indication that the intervention is working to some extent. 
 
Despite the free and regular supply of insulin and blood glucose monitoring equipment to 
the children and adolescents involved in this study, glycaemic control was still poor. This 
indicates that there could be other underlying factors that contribute to poor glycaemic 
control which need to be identified. For instance, a number of factors including irregular 
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supply of insulin, non-availability of structured diabetes programs, and lack of acceptance of 
chronic diseases within the society (employer/school) may contribute to this finding.  
Also, poor socioeconomic conditions as well as non-compliance to the insulin regimen and 
diet are likely to play a major role in the poor glycaemic control observed and consequently 
poor prognosis for the children/adolescents.  In addition, there are biological, behavioural 
and cultural barriers as well as individual/family preferences that affect treatments decisions 
for the patient. These findings highlight the necessity for more efforts in the management 
and follow-up of paediatric type 1 diabetics in Cameroon in order to reduce complications 
resulting from poor glycaemic control. 
 
There are very few studies in Africa which have provided information on glycaemic control. 
For instance, a study by Pillay et al.237 in South Africa among children aged 6 to 10 years 
with type 1 diabetes found a mean glycaemic control of 9.7%. Nevertheless, this study 
included only children six to ten years of age and also had a very small sample size.  
 
It is unclear whether age of the patient and duration of diabetes impact on glucose control. 
The mean duration of diabetes in our study population was 3.8 ± 3.2 years. Even so, there 
was no significant difference in glycaemic control in the different categories of diabetes 
duration, studies carried out in the UK193 and France197 indicate that older age and longer 
duration of diabetes is associated with poor glycaemic control. However, a study by Elbargi 
et al.128 among insulin dependent type 1 diabetics in Sudan indicated a higher incidence of 
poor glycaemic control among younger type 1 diabetics. Nevertheless, this study included 
patients with type 1 diabetes age 6 – 60 years.  Age was however not associated with 
glycaemic control in studies from the US120, New Zealand195, Australia196 and Egypt202. This 
finding is in line with the present study, where no significant association between age or 
duration of diabetes and glycaemic control was observed. 
 
Poor glycaemic control with increasing age among type 1 diabetics may be attributed to a 
decrease in treatment compliance, socio-cultural barriers and less parental involvement or 
supervision in older children. Also, it might be as a result of pubertal hormones from the 
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rapid biological changes associated with the onset of puberty and psychosocial factors in this 
age group.  
 
This current study has shown a significant association between primary caregiver 
involvement and good glycaemic control. This was demonstrated by the significantly lower 
mean HbA1c (8.7%) in children whose primary caregiver was the mother compared to an 
HbA1c of 12.7% in those who had a primary caregiver other than the mother. This could be 
explained by the fact that most often it is the primary responsibility of the mother to care for 
pediatric patients. It could also be an indication of a proper functioning family structure 
because in a case of family dysfunction, the diabetic child will be perceived as a burden and 
this will likely correlate with a higher HbA1c. 
 
The multivariate analysis indicates that mother as the primary caregiver was an important 
determinant in the diabetes management of children and consequently treatment outcome. 
Currently, it is unclear whether it is the involvement of the mother herself which is 
important or whether the fact that the mother is the primary caregiver represents an indicator 
for a setting where good glucose control can be easily achieved.  Nevertheless, in sub-
Saharan Africa there is no known study specifically addressing the issue of primary 
caregiver with respect to the metabolic outcome (as measured by glucose control) in the 
paediatric population with type 1 diabetes. Several studies have demonstrated a significant 
association between maternal knowledge and good glucose control among diabetic children 
whose mothers are the main caregivers. For instance, studies by Al-Odayani et al.214 and 
Soheilipour et al.219 found that children of mothers with more knowledge of diabetes and 
better education irrespective of socioeconomic status were better controlled underscoring the 
importance of the  mother’s knowledge and level of education in the care of diabetic 
children. Also, Tahirovic and Toromanovic217, in a study which investigated the role of 
mother’s diabetes knowledge on glycaemic control in diabetic children in Bosnia and 
Herzegovin, demonstrated that there was improved glycaemic control among children of 
mothers with more diabetes knowledge.   
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Socioeconomic status (SES) has been recognized as an important predictor of type 1 
diabetes outcome190. In the present study, it was noticed that children from low/middle SES 
displayed poor glycaemic control. This finding is consistent with that from other studies 
which have previously shown that low SES was associated with poor glycaemic control 
among children with type 1 diabetes195,199,201,238,239. Similarly, a study by McKinney et al.193 
observed that patients from deprived areas had poorer glycaemic control as compared to 
those from affluent areas. In addition, Overstreet et al.201 in the USA observed that children 
from lower socioeconomic status were found to have an average glycaemic control which 
was 2.2% higher than those of middle SES.  The relationship between poverty and poor 
glycaemic control can be explained by the fact that patients from low income backgrounds 
will be disadvantaged to meet treatment targets due to lack of proper education which is 
necessary for the  management of the disease. 
 
Family living arrangement was not significantly associated with glycaemic control in this 
study. However, it was an important predictor in other studies204,240. For instance a study by 
Thompson et al.205 found that glycaemic outcomes in children from single mother families 
had an average HbA1c of 1.2% higher than those from two parent families. The authors 
attributed this to the fact that single mothers were of a lower income status and had a lower 
level of education. Equivalent findings have been reported by Araujo and Mazza241 in 
Argentina.  
Both parents not living together implies that there will be a few people caring for the patient 
or  family dysfunction problems which might affect the ability to provide the support needed 
for diabetes management and this will have an effect on the glycaemic control of the child. 
 
In this current study, the majority of participants were on multiple daily insulin injections 
which is the currently recommended mode of treatment for patients with type 1 diabetes. 
Surprisingly, it was observed that being on twice daily insulin injections was associated with 
better glucose control than multiple (3 or more) insulin injections. Although this is 
counterintuitive at first glance it may represent the fact that only children not well controlled 
were switched to multiple insulin injections as the “default” management is twice daily 
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insulin injections. Unfortunately, it was not recorded why children were switched to 
multiple injections. 
 
The storage of insulin did not have an effect on the glycaemic control in our study, although 
it can play a role in other African countries126. Temperatures in the North West Region of 
Cameroon frequently go above 25oC, as such the temperature in a pot of sand/charcoal or 
cold water cannot be ascertained. Although insulin can still be left at room temperature for a 
period of one month and it is still safe to be used, it is difficult to guarantee this aspect in 
this part of the country. Nevertheless, refrigeration if available still remains the best choice 
for insulin storage. Data on the temperature inside the pot of sand/charcoal or cold water can 
be collected and if acceptable, it can be used as an alternative method of storing insulin for 
patients without fridges. 
 
The number of diabetic clinic visits has been found to be predictive of glycaemic control 
with irregular clinic attendance being associated with higher levels of HbA1c. Our study 
found a significant association between the number of visits to the healthcare provider and 
good glycaemic control. It has been documented that patients who do not come to clinic 
regularly have difficulties adhering to the different treatment regimens and they have a 
higher risk of diabetes complications242. Frequent visits to the healthcare provider allow for 
more frequent adjustments of insulin regimens and more educational sessions if necessary. 
Similarly, most but not all studies have found that more frequent visits to the diabetic clinic 
resulted in improved glycaemic control120,126,210,211,212.  
 
Knowledge of diabetes is a key component in the management of type 1 diabetes. Also, 
education of both the child and caregiver is of critical importance in ensuring adherence of 
the complex tasks involved in effective diabetes management. In this study, the mean 
diabetes knowledge score for adolescents was 65.4 ± 14.4%.  This is an indication that there 
is a significant diabetes knowledge deficit among the children. Also, there was no significant 
association between diabetes knowledge of adolescents and HbA1c. In addition, studies 
have found that parental diabetes knowledge had an effect on glycaemic control216, 219. For 
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instance, Stallwood et al.218 found that higher parental scores were associated with lower 
HbA1c levels after using all the questions of the Michigan Diabetes Research and Training 
Centre’s brief diabetes knowledge test to assess parental knowledge of diabetes.  There is 
therefore need to emphasize on the key role of parental diabetes knowledge for better 
control in children and adolescents. Unfortunately, parental/caregiver diabetes knowledge 
was not assessed in this study because most parents/caregivers did not complete the section 
of the questionnaire addressing diabetes knowledge for parents/caregivers. 
 
The limitations of this section are that the cut-off level to define “good” glucose control in 
this study was arbitrary considering the distribution of the HbA1c values observed in the 
study population. In addition, given the consistently poor glycaemic control reported in most 
studies from sub-Saharan Africa126,128,236, an HbA1c target of ≤ 9.0% slightly above the 
mean HbA1c levels  attained in the developed nations was used in the study. Also, the 
criteria used to classify participants according to the different socioeconomic backgrounds 
was the Cameroon public service classification of civil servants, which does not adequately 
reflect those in the private sector. However, a study in urban Cameroon has shown the 
World Bank household amenities score to be a better indicator for SES in developing 
economies231.  
 
In addition, the lack of association observed between glycaemic control and age, diabetes 
duration and family living arrangements might be attributed to the small sample size of this 
study.  
 
4.2. Relationship between caregiver involvement in diabetes management and 
adherence to the treatment regimen with glycaemic control. 
Better treatment outcomes are being observed in children and adolescents whose parents and 
guardians are involved in the care of the patients. Family support and involvement of 
parents/guardians is an important modifiable factor and has been found to promote 
adherence and optimal glycaemic control in a study by Anderson et al.206. In addition, a 
recent meta-analysis by Tsiouli et al.209 demonstrated that family conflict was associated 
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with poor glycaemic control.  This present study found a significant association between 
caregiver involvement in the diabetes-related tasks of insulin injection and BGM and good 
glycaemic control. This can be explained by the fact that, in the setting where this study was 
carried out, parents will continuously offer psychosocial support and assume the 
responsibility of care to all sick children regardless of age and degree of maturity by 
providing an appropriate diet and administration of medication. Also, this indicates the 
importance of the parent-child relationship in effective diabetes management because it is 
believed that the way in which the family deals with the disease has an impact on how the 
glycaemic control evolves.   
Similar findings have been reported in other studies207,208. In addition, a study by Berg et 
al.243 on parental involvement in the diabetes management of adolescents with type 1 
diabetes found a direct association between parent-adolescent relationship and monitoring 
with better adherence and glycaemic control. However, research by Lewin et al.244 and 
Sweenie et al.245 have demonstrated poor adherence resulting in poor glycaemic control 
among children of all ages with critical parent-child relationships. Further, Anderson et al.246 
in a study to identify aspects of family behaviour associated with glycaemic control among 
youths (9 to 14 years) found that family conflict was significantly associated with poor 
glycaemic control during this transition period  to adolescence. 
 
The multivariate analysis in this study confirmed that minimal/moderate caregiver 
involvement in the task of insulin injection was a significant independent predictor of poor 
glycaemic control.  
However, it is a well-known fact that family dynamics, stages of development, and 
physiological changes resulting from sexual maturity are important in the development and 
implementation of  an optimal diabetes regimen in adolescents and there is need for a 
balance between adult supervision and self-care as the child reaches maturity. This finding 
has potential clinical implications for intervention as emphasis on optimal caregiver 
involvement in diabetes related tasks of children targeting parents and caregivers could be 
addressed through planned educational programs and this will ultimately improve type 1 
diabetes management and optimize HbA1c in the study setting.  
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Adherence to the different treatment aspects represents an important factor in determining 
good glycaemic control and eventually better treatment outcome. Effective treatment of 
diabetes requires patient adherence to a complex care regimen which encompasses multiple 
insulin administration, frequent BGM and careful monitoring of diet and physical activity. 
This poses a significant burden to children with type 1 diabetes and their families. 
Moreover, adherence to these multiple diabetes tasks is very challenging to diabetic patients 
of all ages especially adolescents who are grappling with rapid biological and hormonal 
changes due to puberty, which tend to antagonize the action of insulin as well as 
independence from parents to increased responsibility for their T1D management.  
In this study, a significant association was observed between good adherence to BGM and 
good adherence to insulin injection and good glycaemic control. However, no such 
association was observed with diet. Some of the reasons given for poor adherence to insulin 
injection included forgetfulness, lack of food and the fact that it was not convenient injecting 
insulin in school and other public places. Also, the most common reason cited for non-
adherence to BGM was laziness. Similar findings have been reported by Borus and Laffel118.   
Several studies have examined the relationship between glycaemic control and adherence 
including Hood et al.121  in a  meta-analysis which demonstrated a negative correlation 
between treatment adherence and HbA1c levels in children and adolescents with type 1 
diabetes. Nonetheless, this was found to be independent of sociodemographic and other 
diabetes specific variables. This points to the fact that glycaemic control improves with 
improved adherence in children and adolescents irrespective of sociodemographic and 
diabetes-specific characteristics.  
Mehta et al.213 demonstrated that greater dietary adherence was associated with lower 
HbA1c levels in young patients with diabetes, a finding that was not confirmed in this study. 
However, the 24 hour recall method of dietary analysis used in this study may not represent 
the habitual nutrient intake.  
 
The lack of association between HbA1c and adherence to diet might be explained by the fact 
that assessment of adherence to the different treatment regimens was by self–reporting. 
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Recall bias could have been possible and over reporting could have resulted in falsely 
elevated adherence levels. Also, adherence to diet was assessed using the 24 hours prior to 
the study, while patient adherence to BGM and insulin was done for the week before the 
study visit and this might not be a true reflection of the patients’ overall adherence in the 
whole country.   
 
This section had some limitations which are worth mentioning. The cross-sectional nature of 
this study cannot show elements of causality. Also, the interpretation of caregiver 
involvement in diabetes related tasks is limited by the fact that the caregiver adjustment was 
not analyzed in an age-adjusted mode.  It was also difficult finding validated tools for 
insulin, dietary and blood glucose monitoring adherence that could be applicable in the 
study setting. BGM adherence can be assessed by downloading data from the blood glucose 
monitors, while dietary adherence can be assessed by counting the calories in the diet. This 
was not performed in our study but should be considered in future trials. 
 
4.3. Diabetic ketoacidosis (DKA) and glycaemic control. 
Diabetic ketoacidosis remains the most common cause of hospitalization and mortality 
among children with type 1 diabetes. Also, children and adolescents with ketoacidosis 
usually have higher levels of HbA1c. The clinical pattern includes polyuria and polydipsia 
as well as fatigue, coma and weight loss as the most commonly reported symptoms at 
diagnosis. 
 
This present study found that less than 30% of children and adolescents presented with DKA 
at diagnosis and this group of patients had a higher mean HbA1c compared to those who did 
not present with ketoacidosis. Nevertheless, there was no significant difference in the 
glycaemic control among the two groups. Also, children/adolescents presenting with DKA 
had elevated plasma glucose levels compared to the non-DKA group. Compared to reports 
from other African countries such as Nigeria247 and Tanzania126, this observed prevalence is 
low. It is difficult making comparisons with other studies given the wide scope of definitions 
used for diabetic ketoacidosis.  
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Similar findings have been reported in other studies148,149,248. For instance, in a study by 
Onyiriuka and Ifebi247 in Nigeria, it was reported that 77.1% of children and adolescents 
presented with DKA at onset of type 1 diabetes. On the contrary, Fritsch et al.249 in a 
multicenter study to determine the incidence and risk factors for DKA among 28,770 type 1 
diabetic children/adolescents < 20 years, from Germany and Austria reported that less than 
5% of the patients presented with one episode of DKA with a significantly higher rate 
reported in females and in children of migrants. 
  
 The frequency of DKA at diagnosis observed in this study was relatively low and this could 
be as a result of the fact that children experiencing severe DKA are not diagnosed correctly 
and may die before the correct diagnosis is made.  
 
The limitation of this section is that clinical evidence for DKA at diagnosis was assessed by 
the presence or absence of certain symptoms or complaints reported by the patient and/or 
caregiver; as such findings on diabetic ketoacidosis should be interpreted with caution. 
Moreover, ketoacidosis is usually defined as blood pH of less than 7.3250, with the severity 
of acidosis categorized into mild, blood pH 7.2 – 7.3; moderate, blood pH 7.1 – < 7.2; and 
severe, blood pH < 7.1. Even so, this was not carried out in our study population. Urinalysis 
was not done for all the patients at diagnosis as such the results cannot be generalized for the 
study population. 
 
4.4. The impact of type 1 diabetes on the daily life of patients. 
The transition to adolescence among youths with type 1 diabetes has been found to be 
associated with unique challenges especially for girls resulting in deteriorating glycaemic 
control, poor adherence to treatment and increased risk of psychological disorders251. In a 
review by Jack252 these challenges were classified into biological influences such as physical 
and emotional changes during puberty, psychological and behavioural factors such as stress 
and sociocultural factors like peer pressure. Hassan et al.253 in a study examining the 
association between psychosocial factors and glycaemic control among children with type 1 
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diabetes  aged 8 to 17 years found that 9.5% of the poorly controlled subjects had depression 
compared to 3% of children with good glycaemic control. The authors also found that the 
quality of life also deteriorated with poor glycaemic control. Also, a study by Hapunda et 
al.254 among adolescents living with type 1 diabetes in Zambia to identify the sources of 
stress as well as the perceived quality of life and care experienced by these adolescents 
found physical, social and psychological factors as the most common sources of stress, 
while quality of healthcare was affected mostly by lack of drugs, lack of proper nutrition and 
low socioeconomic status. 
 
In this study, it was found that more than 70% of the children reported that diabetes had a 
negative impact on their daily life. Nonetheless, there was no significant difference in mean 
HbA1c among children who reported a negative impact on their life and those on whom 
diabetes had no impact.  Given the fact that the perception of the caregiver or children was 
the method used in evaluating the impact of T1D on daily life, it might have contributed to 
the lack of significance in glycaemic control among the two groups. Moreover, an objective 
assessment of type 1 diabetes impact and quality of life of the children were beyond the 
scope of this study.  
 
4.5. Methodological considerations. 
The data used in this current study was obtained from only one region (North West) out of 
the 10 administrative regions in the country. As such findings might not be a true reflection 
of the situation of children living with type 1 diabetes in the country. Moreover, the cross-
sectional nature of this study only allows for the examination of associations but cannot 
show elements of causality. Data from all the 10 regions of the country is necessary for 
effective interventions because the different regions have different cultures and this cultural 
diversity affects patient treatment preferences and health seeking behaviour. Hill255 in a 
study had proposed certain criteria that can be used to examine causality, which are often 
used in epidemiological studies. However, there is no consensus as to whether these 
variables could be applicable in all settings.  
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Also, given the distribution of HbA1c values observed in the study cohort, a compromise 
was made on the HbA1c level used to define “good” glycaemic control. Although the 
current recommendation from the ADA107 state that good glycaemic control is HbA1c < 
7.5%, these goals are very difficult to achieve even in clinical trial settings.  Thus, it was 
demonstrated in the Diabetes Control and complications trial that even in the intensive 
group, the HbA1c level achieved was > 1% higher than the current ADA recommendations 
for the patients in general and in adolescence it was worse partly because this is a period of 
rapid biological changes and they are trying to gain independence from their parents. Studies 
in developed countries120,125,191 have shown that mean HbA1c levels are generally > 8.0% 
despite advances in insulin therapeutics that ease insulin delivery. In addition, adherence to 
the different diabetes regimens is still problematic to children in all age groups especially 
adolescence.  A target HbA1c of < 9.0% was set for this study, a value slightly above the 
mean HbA1c levels attained in the developed nations due to the poor glycaemic control 
reported in most African studies126,128,236. Also, the lack of resources and knowledge deficit 
among patients and their families on the need for optimizing glycaemic control in the study 
setting contributed to the setting of a 1.5% higher HbA1c level target above the 
recommendations of the ADA.  
In addition, the tools used in this study for the measurement of adherence are those used in 
the various clinics to review the children/adolescents because it was not possible to find 
validated tools for insulin, dietary and blood glucose monitoring adherence that could be 
relevant in the study setting. Further, adherence to diet was assessed using the 24 hour 
dietary recall by Geissler and Powers233, adherence to blood glucose monitoring according 
to Hood et al.121 and adherence to insulin according to the Diabetes Control and 
complications trial116 (intensive insulin treatment). 
 
Finally, the findings of this study are only applicable to children/adolescents attending the 
outpatient clinics for children living with type 1 diabetes in Cameroon. Whether or not the 
findings also hold true in other settings cannot be deduced from this study. 
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Despite the limitations of this study, it is strengthened by the fact that it has provided for the 
first time data on predictors of good and poor glucose control among children/adolescents 
with type 1 diabetes in the North West Region of Cameroon. It has also demonstrated the 
importance of a mother in the management of paediatric type 1 diabetes care. In addition, it 
has shown that the active involvement of the caregiver in the task of insulin injection 
optimizes glycaemic control in children and adolescents with type 1 diabetes. The factors 
identified in this study which are significantly associated to glycaemic control are 
modifiable. These findings can contribute in improving the registry’s intervention program 
that is already going on to better address the needs of the children. 
 
4.6. Conclusions and implications.  
This study among type 1 diabetic children in the North West Region of Cameroon shows 
that the mother’s involvement in the diabetes management of their children is a very 
important determinant for good glucose control. The mother as a primary caregiver may just 
be an indicator and not a causal factor for better glucose control. Thus, it may reflect a 
setting related to (but not restricted to) family dynamics, stages of development and 
physiological differences resulting from sexual maturity allowing better glucose control. 
 
The main findings of this study are summarized as follows: 
• Despite the free and regular supply of insulin and blood glucose monitors through 
Changing Diabetes in Children (CDiC) program, glycaemic control among children 
and adolescents with type 1 diabetes attending the clinics for children living with 
diabetes in the North West Region of Cameroon remains very poor.  However, there 
was a significant decrease in HbA1c from diagnosis to the study period. 
• Being on twice daily insulin injections was associated with better glycaemic control. 
• Younger age, shorter diabetes duration and family living arrangements did not 
influence glycaemic control. 
• There was a significant association between adherence to insulin injection and 
adherence to BGM with glycaemic control. However, there was no significant 
association between diet and HbA1c.  
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• More visits to the diabetic clinic were found to be significantly associated with good 
glyceamic control. 
• Having a mother as the primary caregiver and minimal/moderate caregiver 
involvement in the task of insulin injection were significant independent predictors 
of good and poor glycaemic control respectively. 
• Type 1 diabetes was found to have an impact on the daily life of patients. 
 
The study findings have potential implications for effective interventions in the delivery of 
care for children/adolescents with type 1 diabetes, prevention and for future studies. 
 
This study has demonstrated that glycaemic control is still poor among children and 
adolescents in the North West Region irrespective of the fact that the intervention through 
CDiC provides free insulin and blood glucose monitors. Most interventions on type 1 
diabetes in children have been carried out in developed countries. The Changing Diabetes in 
Children program is the first intervention in Cameroon for children living with type 1 
diabetes. Even though the program appears to be working, the mean glycaemic control 
among the children remains poor with values above the recommended ADA target of < 
7.5% as well as the set target in this study (HbA1c < 9.0%). It is important to note that 
although most of the children have poor glycaemic control, they could have been much 
worse if they were not included in the program at all. 
The implications for the above are that since the management of diabetes requires a complex 
treatment approach, any intervention should therefore focus on the aspects of behaviour 
(individual level), and culture (population level) which could play a vital role in 
understanding why most of the children and adolescents in our setting had high levels of 
HbA1c. Also, metabolic control is only one of the approaches of maintaining good glucose 
control as such focusing on biochemical parameters alone is unlikely to prevent 
deterioration in glycaemic control in this setting. In addition, individual and population level 
factors may contribute in understanding why younger age and shorter diabetes duration were 
not significantly associated with glycaemic control in our study. In actual fact, a study in 
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Sudan among type 1 diabetics also found that younger age was not significantly associated 
with good glycaemic control128. 
 
Also, given the complexity involved in the management of diabetes, diversity of cultures as 
well as the individual/family preferences in the different ethnic groups in the country that 
could affect treatment decisions for patients, healthcare providers need to make use of 
strategies like the trans-cultural patient care256,257. This approach would not only build 
confidence in patients, it could promote the use of culture among health professionals258. 
This can lead to better adherence to treatment especially among adolescents as well as 
inspire the health professionals to follow up this group of patients. It is worth noting that 
Cameroon has 10 regions with different cultures. There is therefore need to start identifying 
individual and cultural factors in the different regions that could affect treatment decisions 
for patients and this will help in reducing the rates of poor glycaemic control among type 1 
diabetic children.  Also, these factors could be crucial in understanding why family living 
arrangement was not significantly associated with glucose control in this study. In addition, 
these cultural factors could help the responsible persons of the registry to better address the 
needs of these diabetic children given the fact that some cultural factors that could improve 
the management of the disease in one region might not be applicably or effective in other 
regions. 
 
Late diagnosis is as a result of ignorance and lack of knowledge. Therefore from an 
epidemiological point of view, public awareness (through educational programs) needs to be 
created especially focusing on healthcare professionals, parents, and caregivers to sensitize 
them on the early signs of diabetes because only a higher level of public awareness can 
prevent missed and delayed diagnosis and improve metabolic control in this paediatric 
population. Nonetheless, a study in India found a significant improvement in the knowledge 
and attitude but no improvement in HbA1c levels after a planned educational intervention 
program on the attitudes, knowledge, and practices of type 1 diabetics221.  
Our study demonstrated that having a mother as a primary caregiver and that 
minimal/moderate caregiver involvement in the task of insulin injection were significantly 
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associated with good and poor glucose control as measured by HbA1c respectively. This 
indicates that effective educational intervention addressing knowledge deficiencies should 
begin at the level of the family (especially parents/and caregivers) and then the  rest of the 
family as more educational sessions on the importance of optimal involvement in the 
diabetes care of children will increase their knowledge of the disease management and 
ultimately improved glucose control among the children. 
Socioeconomic status was not significantly associated with glycaemic control in this study. 
Most epidemiological studies often use educational level, income and occupation as 
indicators of SES and there is a possibility that these variables could be inter-related. Since 
this study involved children and adolescents (who depend mostly on their parents because 
they might be unable to earn a living on their own), their SES could only be determined 
using that of their parents. In the present study it was the Cameroon public service 
classification of civil servants of income and occupation. There is no best way of estimating 
SES since the different indicators could represent different concepts of SES259. A previous 
study by Fezeu et al.260 indicated that in Cameroon, educational level seems not to be a good 
indicator for SES as being educated is not usually associated with a good income.  Our study 
made use of occupation and income in order to demonstrate their contribution and impact on 
health inequalities with respect to type 1 diabetes in children. The implications of the above 
is therefore that any intervention to improve on type 1 diabetes management and outcome in 
children should target the rural areas in particular and then extend to the urban areas of the 
country since this study has  found that a majority of the study participants were from the 
rural area and of low SES. 
From a dietary perspective, there was no significant association between adherence to diet 
and glycaemic control. Also, there is variation in the staple foods consumed by the different 
ethnic groups in the different regions of the country. The implications of the above finding is 
that dietary adherence will continue to be poor if something is not done to enable the 
children to be able to quantify the calories in their diet given the fact that there is no food 
composition data that could be of help in quantifying the nutrient intake of the children.  
There is therefore need to make an assessment of the nutrients and calories found in the 
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staple foods frequently consumed by the different ethnic groups. The use of nutrient 
composition data to assess foods consumed by these children could contribute in 
understanding why only a tenth of the study participants had good dietary adherence.  
Further research should be carried out in children in other type 1 diabetic clinics in the other 
regions of the country because the findings may slightly differ between regions due to the 
cultural diversity in the country. Finally, there is a need to start etiological and prevention 
research in the country and this should target behavioural, biological and the environmental 
factors that could help in implementing effective strategies to prevent deterioration in type 1 
diabetes control in the country and rural sub-Saharan Africa. 
 
5. SUMMARY  
Like the rest of the world, some families in sub-Saharan Africa (SSA) are also affected with 
type 1 diabetes. In contrast to Western countries, type 1 diabetes is associated with a very 
poor prognosis in sub-Saharan Africa with many patients not being diagnosed and those 
diagnosed having a life expectancy of less than a year. In developed countries, a variety of 
factors that predict the outcome of children with type 1 diabetes has been documented while 
there is limited information on predictors of outcome in sub-Saharan Africa.  
In Cameroon, the "Changing Diabetes in Children" (CDiC) program is an intervention, 
which helps to increase access to care for children suffering from type 1 diabetes and the 
key components of the program include therapy supplies, education and training of 
healthcare professionals for early diagnosis and adequate management of type 1 diabetes. 
This study identifies that mother as a primary caregiver and the involvement of the caregiver 
in diabetes related task can help in improving glucose control in children and adolescents 
with type 1 diabetes in the North West Region of Cameroon.  
These findings are to help members of the registry to improve on the current intervention in 
the country. 
 
Chapter 1 of this thesis exploits the different forms of diabetes leading to the description of 
type 1 diabetes as well as the genetics, immune markers and the environmental risk factors 
involved in the pathogenesis of the disease. It then exploits the literature on the global 
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situation looking at the incidence and prevalence of type 1 diabetes from a global 
perspective leading to the situation in Cameroon. The different diabetes complications 
which depend on glucose control, potential predictors of glycaemic control and the 
challenges in diabetes management are presented.  
 
The method used in the study, the study participants, study site and the management of 
patients is presented in chapter 2. This study included 76 children and adolescents with type 
1 diabetes in the North West region of Cameroon. Also, a convenience sampling technique 
was used because the patients were involved in a national program that is already running in 
hospital clinics in the country and data was collected from all the children that were included 
in the program who consented to the study. The study investigated predictors of good and 
poor glycaemic control using information on diabetes-related characteristics and practices, 
clinical and biochemical parameters as well as sociodemographic characteristics. 
 
Chapter 3 presents the main characteristics of the study population, the differences in 
clinical and biochemical characteristics before diagnosis and during the study period and the 
mean HbA1c by diabetes specific characteristics. The findings show that children whose 
mothers are the primary caregivers have better glycaemic control compared to those having 
someone other than the mother as a primary caregiver. This is then followed by the 
association between caregiver involvement in diabetes–related activities and patient 
adherence which indicate that optimal caregiver involvement in diabetes related activities 
translate to better glycaemic control.  Binary logistic regression analysis to identify potential 
determinants of poor glycaemic control followed by multivariate analysis demonstrate that 
children with minimal/moderate caregiver involvement in the task of insulin injection are at 
risk of poor glycaemic control as measured by HbA1c. Further, it was confirmed from the 
multivariate analysis that having a mother as a primary caregiver is an important predictor of 
good glycaemic control in the children. 
 
This study has shown that glycaemic control among children and adolescents in the study 
setting is very poor despite the free and regular supply of insulin and free glucose monitors. 
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This point to the fact that there is still a huge knowledge gap between the standards of 
medical care and practice as well as some underlying individual and population level 
determinants causing poor control in the children/adolescents included in the CDiC program 
which need to be identified to help members of the diabetes registry to modify the current 
intervention or design future interventions 
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9. APPENDIX 
 
APPENDIX 1:   Parent Questionnaire  
Please complete all the questions on this questionnaire which will take about 30 
minutes of your time  
                Patient code  
 SOCIODEMOGRAPHIC DATA AND BACKGROUND INFORMATION  
1. Telephone contact __________________ 
2. Residence____________________________      
3. What is your child’s date of birth (day/month/year): _________________ 
4. When was your child diagnosed of diabetes 
(day/month/year):______________________  
5. What was your child`s age at diagnosis of diabetes mellitus?___________________ 
6. What is your child`s body weight (Kg) __________ 
7. What is the height of your child (m) _________ 
8. For how long have your child been living with diabetes? ___________ 
9. Primary caregiver (Please circle the right answer)  Example: a.  Mother     b. Father   
                  a. Mother   b. Father   c. Brother/Sister d. Other – specify __________________ 
10. What is your child`s insulin regimen: (Please circle the right answer).  
a.  Multiple daily insulin injections b.  2 daily insulin injections 
11. What is the highest level of education completed by the primary caregiver of your 
child? (circle the right answer): 
a. No formal education     b.  Primary    c. Secondary    d. High school   e. 
University 
12.  What is your family structure (select one and circle the right answer): 
a. Both parents are living together    b. Single parent family     c. Not living with 
either parent      d. Orphan 
13. Is there any other member of your family suffering from type 1 or type 2 diabetes? 
(circle the right answers) 
a. Mother    b. Brother/Sister   c. father     d. Uncle/Aunt      e. Grandparent   f. 
None 
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14. At the time of diagnosis did your child have any of the following; (Circle the right 
answer) 
- Ketones in the urine                      a. Yes        b. No 
- Altered consciousness or coma     a. Yes       b. No         
15. How many times have your child been found to have the following in the last 6 
months?  
-Presence of ketones in urine_________________________ 
-Weakness or sweating or vomiting________________________ 
-Admission to hospital over the last 6 months________________ 
16. Does your child suffer from any of the following? (Circle the right answers). 
a. Dizziness  b.  Poor memory  c.  Lack of energy   d.   Coma/Convulsion 
 
17. How many times have your child experienced any of the above during the last 6 
months ____________________________  
 
18. Did your child suffer from any of the following when he/she was young? (Circle the 
right answers!) 
a. Measles  b. Weight loss c. Eczema  d. weakness  e. Mumps   f. Diarrhea     h. 
none  
19. Was your child suffering from any of the following at the time of diagnosis? (Circle 
the right answers!) 
a. Cold  b. coma  c. weakness    d. stomach problems  e. Weight loss       
f. weakness  g. none 
For how long did your child suffer from it before being diagnosed of diabetes? ____ 
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20. Socioeconomic status (circle the right answer) 
MOTHER FATHER 
1-Number of children  1- Number of children 
2-What is your highest level of education? Please 
tick one! 
a. None  b. Primary  c. Secondary  d. High 
School     e. University 
2- What is your highest level of education? 
Please tick one 
a) None  b. Primary  c. Secondary  d. High 
School        e. University 
3-What is your occupation? 3-What is your occupation? 
4-Can you give an estimate of your household 
income in a month (from all available sources) 
Please tick one. 
a)  Below 25,000frs    b)  25,000frs - 50,00frs  
c) 50,000frs - 100,000frs     
d) 100,000frs -  200,000frs 
e) 200,000frs – 300,000frs   
f)  300,000frs – 400,000frs 
g) 400,000frs and above 
4-Can you give an estimate of your 
household income in a month (from all 
available sources) Please tick one. 
a)  Below 25,000frs   b)  25,000frs - 50,00frs  
c)  50,000frs - 100,000frs     
d) 100,000frs -  200,000frs 
e)  200,000frs – 300,000frs    
f)  300,000frs – 400,000frs 
g) 400,000frs and above 
5- What is your religion? 
a. None     b. Catholic      c. Protestant       d. 
Muslim   e. Other………………  
5- What is your religion? 
a. None     b. Catholic      c. Protestant       d. 
Muslim      e. Other………… 
     
I. DIABETES KNOWLEDGE ASSESSMENT 
(Assessed using the Michigan Diabetes Research and Training Center’s brief diabetes 
knowledge test) 
 
A. DIABETES KNOWLEDGE ASSESSMENT OF CAREGIVERS: (Please tick the 
right answer) 
1. Which of the following is highest in carbohydrates? 
a. Chicken  b.  Fish         c. Potato       d. Butter 
2. Which of the following is highest in fats? 
a. Milk b.  Orange juice      c.  Maize         d. Honey 
3. Which is the best method for testing your child’s glucose? 
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a. Urine testing   b. Blood testing   c. Both are equally good 
4. What effect does unsweetened fruit juice have on your child’s blood glucose? 
a. It lowers blood glucose   b. It raises blood glucose   c. It has no effect on 
blood glucose 
5. What effect does exercise have on the level of blood glucose? 
a. It raises blood glucose  b. It lowers blood glucose   c. It has no 
effect on blood glucose 
6. Having an infection is likely to cause which of the following? 
a. A decrease in the blood glucose      b. An increase in the blood glucose     c. 
No change in the blood glucose  
7. Tingling and numbness may be symptoms of which of the following? 
a. Eye disease     b. Nerve disease c.  Kidney disease   d.  Liver disease 
8. Which of the following is usually not associated with diabetes? 
a. Nerve problems b. Lung problems   c. Eye problems    d.  Kidney 
problems 
9. Signs of ketoacidosis (very high blood sugar) include: 
a. Shakiness b. Sweating c. Vomiting 
10. If your child is sick with the flu, which of the following changes would you tell 
her/him to make? 
a. Take less insulin   b. Drink less liquids   c. Eat more proteins   d. Test 
for blood glucose more often 
11. You realize just before lunch time that your child forgot to take his/her insulin before 
breakfast. What should you advise him to do now? 
a. Skip lunch to lower blood glucose 
b. Take the insulin that he/she usually takes at breakfast 
c. Take twice as much insulin as he/she usually takes at breakfast 
d. Check his/her blood glucose level to decide how much insulin to take 
12. Low blood glucose may be caused by which of the following? 
a. Too little insulin    b. Too much insulin    c. Too much food       d. Too 
little exercise 
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13. If your child takes morning insulin but skips breakfast, his/her blood glucose level 
will usually: 
a. Increase  b.  Decrease c.  Remain the same 
14. High blood glucose may be caused by: 
a. Not enough insulin 
b. Skipping meals 
c. Delaying your food 
15. Glycosylated haemoglobin (haemoglobin A 1) is a test that is a measure of your 
average blood glucose level for the past: 
a.  Day     b.   Week        c.   3 months            d. 6 months 
16. What was your child`s last HbA1c level? _________________________________ 
 
II. DIABETES RELATED PRACTICES OF PATIENT/CAREGIVER 
1. Is there anybody at the clinic/health centre that your child can contact in case of any 
problems for advice?      a) Yes      b)  No 
2. Was your child given clear instructions on how to handle his/her dose of insulin or 
inject your insulin?                   a) Yes        b) No  
1.  How many doses of insulin have your child missed in the last one week? 
a) None                b) Between 1 – 3 times             c) More than 3 times 
2.  How many times have your child measured his/her blood glucose at home in the last 
one week?            
  a) Every day       b) More than or 3 times a week     c) 1 – 2 times a week    d)  less 
than Once a week 
3. What did your child eat in the last 24 hours? 
During breakfast _____________________________________________________ 
For lunch _________________________________________________________ 
During supper __________________________________________________ 
        Any snacks? (How many times?) ___________________________________ 
4.  How does your child store his/her insulin?     a) Refrigerator              b)  Pot of cold 
water        c)  Room temperature 
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5.  In the last 24 hours, how many times did the parent/caregiver inject or supervise the 
insulin injection of his/her child? 
         a) None             b) Once or twice           c) All the injections 
        7. How involved is the parent/caregiver in the testing/measurement of his/her child`s 
blood glucose?  Please tick! 
a) No involvement 
b) Reminds the child to monitor glucose or logs in the level in the diary or asks about 
the blood glucose level 
c) Sets up the meter and does the finger prick 
         8.  How many times did your child visit the doctor/clinic during the last 6 months? 
                a) None                         b) Between 1-3 times                 c) More than 3 times 
         9.  Have your child been admitted to the hospital over the last year?         a) Yes  b) 
No.       If the answer is Yes 
             -How many times? _________________________________________________ 
             -How many days? _________________________________________________ 
             -What was the reason for your child’s admission __________________________ 
 
III: AVAILABILITY OF INSULIN 
1. In the last 3 months, have your child ever missed getting his/her prescribed insulin from 
the hospital?                      a) Yes                  b) No 
2.  If Yes, how frequently have your child missed his/her supplies?        
 a) Every month                   b) Once or twice in 3 months 
3. When your child misses his/her supplies of insulin or syringes, what does he/she usually 
do? 
a) Buy his/her own insulin    b) Wait till supplies of insulin are available from the 
hospital 
 
IV:  THE IMPACT OF DIABETES ON DAILY LIFE AND LOCAL FACTORS  
1. Does your child frequently miss school due to diabetes and related complications?     
 a) Yes            b) No      If Yes, in the last 1 month, how many missed days of 
school? ___ 
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2. Does having diabetes affect your child`s performance in school?     a)Yes        b)  No 
3. Does having diabetes restrict your child from regular sports?           a)Yes       b)  No 
If No, how many times do you do sports a week? __________________________ 
4. Does having diabetes cause your child to isolate him/herself from friends?   
a) Yes          b) No 
5. Does having diabetes sometimes make your child unhappy?         a)Yes            b) No 
6. Has having diabetes had a positive impact on the life of your child?    a) Yes    b) No 
 If Yes, in what way? _______________________________________________ 
7. Is your child suffering from any diabetes related complications?     a)Yes         b) No 
If Yes, which complications? __________________________________________ 
8. Has your child`s diabetes increased your responsibilities towards him/her?      
a) Yes           b) No               If Yes how? ____________________________ 
9. Does having diabetes restrict your child from eating certain foods?      a) Yes     b) 
No 
        If Yes, which foods? _____________________________________________ 
10. Does your child sometimes eat the foods the doctor asked him/her not to eat?   
 a) Yes        b) No               If Yes, why?_________________________ 
11. Does your child follow strictly the advice of the doctor on the kinds of food he/she is 
supposed to eat?      a) Yes              b. No          If No, why? ___________________ 
12. Are there any other ways that having a chronic disease like diabetes affects the daily 
life of your child? __________________________________________ 
13. Is there anybody or child living with diabetes that your child admires?     a) Yes      
b) No 
14. How much does your child pay for transport from your house to the clinic or health 
centre? _________ 
15. Have you ever visited a herbalist because of your child`s diabetes?    a) Yes          b) 
No 
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Child/Adolescent   Questionnaire 
 
B. DIABETES KNOWLEDGE ASSESSMENT OF CHILD/ADOLESCENT: 
(Please tick the right answer) (ONLY FOR CHILDREN ABOVE 10 YEARS) 
 
1. Which of the following is highest in carbohydrates? 
a. Chicken             b.  Fish               c. Potato                 d. Beans 
2. Which of the following is highest in fats? 
a. Milk             b. Orange juice        c. Maize             d. Honey 
3. Which is the best method for testing glucose? 
a. Urine testing                 b. Blood testing            c. Both are equally good 
4. What effect does unsweetened fruit juice have on your child’s blood glucose? 
a. It lowers blood glucose  b. It raises blood glucose   c. It has no 
effect on blood glucose 
5. What effect does exercise have on the level of blood glucose? 
a. It raises blood glucose  b. It lowers blood glucose   c. It has no 
effect on blood glucose 
6. Having an infection is likely to cause which of the following? 
a. A decrease in the blood glucose      b. An increase in the blood glucose     c. 
No change in the blood glucose  
7. Tingling and numbness may be symptoms of which of the following? 
a. Eye disease     b. Nerve disease c.  Kidney disease   d.  Liver disease 
8. Which of the following is usually not associated with diabetes? 
a. Nerve problems b. Lung problems   c. Eye problems    d.  Kidney 
problems 
9. Signs of ketoacidosis (very high blood sugar) include? 
a. Shakiness       b.  Sweating     c.  Vomiting 
10. If you are sick with the flu, which of the following changes should you make? 
a. Take less insulin    b.  Drink less liquids     c.  Eat more proteins    d. Test for 
glucose more often 
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11. You realize just before lunch time that you forgot to take your insulin before 
breakfast. What should you do now? 
a. Skip lunch to lower your blood glucose 
b. Take the insulin that you usually take at breakfast 
c. Take twice as much insulin as you usually take at breakfast 
d. Check your blood glucose level to decide how much insulin to take 
12. Low blood glucose may be caused by which of the following? 
a. Too little insulin     b.  Too much insulin      c. Too much food     d.  Too little 
exercise 
13. If you take your morning insulin but skip breakfast your blood glucose level will 
usually? 
a. Increase        b. Decrease      c. Remain the same 
14. High blood glucose may be caused by? 
a. Not enough insulin 
b. Skipping meals 
c. Delaying your food 
15. Glycosylated haemoglobin (haemoglobin A 1) is a test that is a measure of your 
average blood glucose level for the past: 
a.  Day     b.   Week        c.   3 months  d. 6 months 
16. What was your last HbA1c level? ____________________________ 
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